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Abstract
A new dataset of cosmetics-related chemicals for the Threshold of Toxicological 
Concern (TTC) approach has been compiled, comprising 552 chemicals with 219, 40, 
and 293 chemicals in Cramer Classes I, II, and III, respectively. Data were integrated 
and curated to create a database of No-/Lowest-Observed-Adverse-Effect Level 
(NOAEL/LOAEL) values, from which the final COSMOS TTC dataset was developed. 
Criteria for study inclusion and NOAEL decisions were defined, and rigorous quality 
control was performed for study details and assignment of Cramer classes. From the 
final COSMOS TTC dataset, human exposure thresholds of 42 and 7.9 µg/kg-bw/day 
were derived for Cramer Classes I and III, respectively. The size of Cramer Class II 
was insufficient for derivation of a TTC value. The COSMOS TTC dataset was then 
federated with the dataset of Munro and colleagues, previously published in 1996, 
after updating the latter using the quality control processes for this project. This 
federated dataset expands the chemical space and provides more robust thresholds. 
The 966 substances in the federated database comprise 245, 49 and 672 chemicals 
in Cramer Classes I, II and III, respectively. The corresponding TTC values of 46, 6.2 
and 2.3 µg/kg-bw/day are broadly similar to those of the original Munro dataset.  
 
Keywords  
Threshold of Toxicological Concern; TTC; cosmetics; cheminformatics; Cramer 
classification 
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Graphical Abstract 
 
 
Highlights 
 COSMOS TTC dataset is a new TTC dataset comprising 552 cosmetics-
related chemicals. 
 It expands the coverage of chemical space for cosmetics-related chemicals. 
 Human thresholds of 42 for Class I and 7.9 μg/kg-bw/day for Class III are 
derived. 
 No human threshold is proposed for Cramer Class II due to insufficient data. 
 Combining COSMOS and Munro datasets gives similar thresholds to Munro 
TTC values. 
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1 INTRODUCTION 
The Threshold of Toxicological Concern (TTC) is a risk assessment approach that 
can be used to screen substances with few or no toxicological data for which human 
exposures are likely to be low. The TTC approach utilizes generic human exposure 
threshold values (TTC values) that have been derived from oral experimental data on 
cancer and non-cancer toxicity endpoints. If human exposure to a substance is below 
the relevant TTC value, it can be judged “with reasonable confidence, to present a low 
probability of a risk” (Munro, Ford, Kennepohl, & Sprenger, 1996). The work 
presented here was undertaken in order to underpin and facilitate the use of the TTC 
approach for substances found in cosmetics. 
The TTC approach was inspired by, and can be considered an extension of, the 
Threshold Of Regulation (TOR) that was adopted by the US Food and Drug 
Administration (FDA) for substances used in food-contact articles (US Food and Drug 
Administration, 1993, 1995). The original TOR concept used a single threshold for all 
chemicals, based on the conservative assumption that an untested chemical could 
pose a cancer risk, even though it was not intended to be used for chemicals with 
structural alerts or other reason for concern for genotoxicity. Tetra sodium 
ethylenediaminetetraacetate (EDTA) (Chemical Abstract Services Registry Number 
[CAS RN]: 64-02-8) was the first chemical to which TOR was applied in 1996 at US 
FDA Center for Food Safety and Nutrition (CFSAN)2. It was subsequently expanded 
into the TTC concept to include non-cancer endpoints by Munro et al. (1996) and 
further elaborated by Kroes et al. (2004), who proposed the addition of another tier 
intended to be protective for DNA-reactive carcinogens.  
The TTC approach was originally developed for substances present at low levels in 
the diet and consumed orally (Barlow, 2005) and was used by JECFA for evaluating 
                                                          
2
 Information provided by Kirk Arvidson at the Office of Food Additive Safety of US FDA CFSAN 
https://www.accessdata.fda.gov/scripts/fdcc/index.cfm?set=TOR&id=1996-001. 
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flavouring substances. It was subsequently evaluated in detail for use in food safety 
by the European Food Safety Authority (EFSA) (EFSA, 2012). Improvement and 
expansion of the TTC approach were also discussed in an Expert Workshop 
convened by EFSA and the World Health Organisation (WHO) in 2014 (EFSA/WHO, 
2016). Application of the TTC approach has also been proposed for, or extended to, 
the risk assessment of other types of substances. These include substances present 
in consumer products (Antignac et al., 2011; Blackburn et al., 2005; SCCS, SCHER, 
SCENIHR, 2012; SCCS NfG, 2016): micropollutants, drug residues,, pesticide 
metabolites and other impurities in drinking water (Brüschweiler, 2010; EFSA, 2016; 
Houeto et al., 2012; Laabs, Leake, Botham, & Melching-Kollmuß, 2015; Melching-
Kollmuß, Dekant, & Kalberlah, 2010; Mons et al., 2013); genotoxic impurities in 
human pharmaceuticals (EMEA, 2006); herbal preparations (EMEA, 2008); 
homeopathic medicines (Buchholzer, Werner, & Knoess, 2014); and human 
pharmaceutical substances carried over in multiproduct manufacturing facilities 
(Bercu & Dolan, 2013; Stanard, Dolan, Hanneman, Legare, & Bercu, 2015). It has 
also been used as a first-level screening tool to prioritize for review a large number of 
substances identified as needing an assessment under the Canadian Environmental 
Protection Act (Health Canada, 2016). Consideration has also been given to whether 
the TTC approach could be applied to human biomonitoring data (Becker, Hays, 
Robison, & Aylward, 2012) and to human exposures by non-oral routes (Carthew, 
Clapp, & Gutsell, 2009; Escher et al., 2010; Hennes, 2012; R Kroes et al., 2007; 
Partosch et al., 2015).  
The original reference dataset (Munro et al., 1996) consisted of 613 organic 
substances representing a “range of industrial chemicals, pharmaceuticals, food 
substances and environmental, agricultural and consumer chemicals likely to be 
encountered in commerce”. Although the intent was to cover a broad chemical 
domain, the dataset is now over 20 years old, and questions have been raised as to 
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whether it is adequately representative of chemicals and structures used in contexts 
other than its original application in food (Dewhurst & Renwick, 2013). This issue was 
first raised in relation to cosmetics by Blackburn et al. (2005) and was an important 
consideration for the use of TTC for chemicals in cosmetics and consumer products in 
the opinion of the European Commission’s non-food Scientific Committees (SCCS, 
SCHER, SCENIHR, 2012). The Scientific Committees stated that the TTC approach 
is scientifically acceptable, whilst noting some concerns, including that all risk 
assessment approaches have some degree of uncertainty, that many complex 
chemical structures are not adequately represented in currently available databases, 
and that there is limited knowledge of effects due to dermal and inhalational exposure 
routes that are more common for consumer products (SCCS, SCHER, SCENIHR, 
2012). 
Better understanding of the applicability of the TTC concept to substances present in 
cosmetic products would be particularly valuable because of the impact of the 
European Union (EU) Regulation that prohibits the marketing of cosmetic products 
and ingredients that have been tested on animals after 2009 or 2013 (European 
Commission, 2009). To this end, the COSMOS project developed a Cosmetics 
Inventory for substances used or potentially found (e.g., as a contaminant or 
packaging migrant) in cosmetics as a reference look-up table. A search was then 
conducted across publicly available databases for toxicity data on all the substances 
in the Inventory. Only about 10% of the substances in the Inventory had toxicity data 
with NO(A)EL/LO(A)EL (No/Lowest-Observed-Adverse-Effect Level) values from 
regulatory submissions and the scientific literature. These substances forming the 
intersection of the toxicity database and the Cosmetics Inventory were then identified 
as initial candidates (Figure 1) and further developed into a COSMOS TTC dataset in 
this project. The oral TTC values relevant to cosmetics have been derived and can be 
compared with the previously established generic human exposure thresholds (Kroes 
et al., 2004; Munro et al., 1996).  
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Figure 1 Identification of candidate collection to be developed for COSMOS TTC dataset 
The COSMOS project was part of the European research initiative with the long-term 
goal of achieving "Safety Evaluation Ultimately Replacing Animal Testing" (SEURAT-
1), co-funded by the European Commission and Cosmetics Europe. The overall aim 
of the COSMOS project was to develop computational methods that can serve as 
viable alternatives to toxicity testing in animals for cosmetic ingredients. Derivation of 
TTC values from a cosmetics toxicity dataset would provide higher confidence in the 
use of the TTC approach in that context. 
COSMOS project set up two collaborative working groups co-ordinated by ILSI 
Europe. One group addressed dermal-to-oral extrapolation, using a flux decision-tree 
approach, to derive dermal systemic exposures for comparison with oral TTC values 
(Williams et al., 2016). The other group addressed whether the chemical space of 
cosmetics ingredients was adequately reflected by the chemicals in the current TTC 
database. First, it was necessary to define the chemical space of cosmetics-related 
chemicals; hence the COSMOS Cosmetics Inventory was developed by the 
COSMOS project and is described in detail elsewhere (Cronin et al., 2012). In this 
publication, we focus on the use of the curated COSMOS TTC dataset of non-cancer 
endpoints for derivation of TTC values for cosmetics-related chemicals. 
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2 MATERIALS AND METHODS 
The workflow for this project was complex and is summarized here to orient the 
reader. First, it was necessary to define what chemicals can be considered as 
“cosmetics-related” by establishing a look-up inventory. At the start of the project 
(2011), the EU (CosIng) database was still being developed and did not provide a 
public resource for a complete inventory. The COSMOS Cosmetics Inventory, 
containing 20,974 substances, was therefore developed. Extensive searches were 
then conducted across publicly available sources for toxicity data on all the 
substances in the Inventory. To be usable, the toxicity data was constrained to that 
which had numeric endpoints, i.e. NO(A)ELs/LO(A)ELs. From these searches on the 
20,974 substances in the Inventory, just over 2,000 substances with 
NO(A)EL/L(O)AEL values were identified (see Figure 1). From this initial data 
compilation, it was evident that certain chemical classes needed to be enriched. 
Therefore, a new database was built, called “oRepeaTOX”, which added 228 
cosmetics-related chemicals, including ones from new chemical classes such as hair 
dyes, preservatives, UV filters, and relevant impurities. The oRepeaTOX database 
was merged with the initial toxicity data compilation into the COSMOS database, 
containing over 2,300 substances. From this COSMOS database, a new 
NO(A)EL/L(O)AEL database, containing 1,059 chemicals was built by applying study 
selection criteria. A further set of rules was then applied to determine a point of 
departure for each chemical, to be used for calculation of TTC values. This resulted in 
a final COSMOS TTC dataset of 552 chemicals. The workflow is outlined in Figure 2 
and each part of the process is described in more detail below. 
2.1 COSMOS Cosmetics Inventory 
The development of the new TTC database for cosmetics-related chemicals begins 
with the ability to identify the substances as such, as depicted in Figure 1. Due to the 
 14 
 
complexity of use and product categories and differing regulatory or reporting systems 
for cosmetics ingredients in the EU and the United States of America (USA), a 
centralized inventory was needed as a reference library to define the “cosmetics-
related” chemical space. The COSMOS Cosmetics Inventory is a listing of cosmetics 
ingredients (although they are not all intentionally used in cosmetics) and other 
substances that have been reported to be present in cosmetics products in the EU 
and the USA. The Inventory was prepared by merging the substance lists from the 
European Union CosIng (Cosmetic Ingredients) (European Commission, 2012) and 
the US Personal Care Products Council (Personal Care Products Council, n.d.) 
(Bailey, 2011) Databases. The Inventory includes the International Nomenclature for 
Cosmetics Ingredients (INCI) name, the CAS RN, the European INventory of Existing 
Commercial Substances (EINECS) number, function (according to EU CosIng), and 
product category (USA). The COSMOS Cosmetics Inventory contains 9,876 unique 
CAS RN and 19,473 unique INCI names. Approximately 50% of the inventory 
comprises botanicals, animal fats, polymers, resins and UVCBs (substances of 
Unknown or Variable composition, Complex reaction products or Biological materials), 
which are not amenable for TTC or computational approaches due to their poorly 
defined chemical structure. Based on this substance inventory, a set of 5,270 test 
substances (4,740 unique chemical structures) were identified and were used to 
define the chemical domain for TTC analysis. Further information on the compilation 
of the inventory can be found elsewhere (Cronin et al., 2012). The Inventory is freely 
available within the COSMOS Database (COSMOS DB) v2.0 (Molecular Networks, 
2017). 
2.2 Development of databases 
The curation strategy for obtaining the final COSMOS TTC dataset required rigorous 
database constructions across three phases, summarized in Figure 2. The first phase 
(1) was the construction of a new oral toxicity database, the oRepeaTOX DB, to 
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enrich the COSMOS database with detailed study result information from 228 
cosmetics-related chemicals (i.e. cosmetics ingredients and unintentionally added 
chemicals found in cosmetics product formulations, such as packaging migrants). This 
new oRepeaTox DB was then added to the existing collection of toxicity data from 
sources providing rather NO(A)EL/LO(A)EL values than detailed study result 
information, described in Figure 1 as the initial candidates and labelled in Figure 2 as 
“Other Data Sources (>2,000 chem)”. Together these two sources provided toxicity 
data for more than 2300 chemicals. The second phase (2) was to filter studies 
appropriate for TTC to compile a database with the NO(A)EL and LO(A)EL values. 
There were 1,059 chemicals covering 1,357 studies in this NO(A)EL/LO(A)EL 
database. The third phase (3) was then to further refine the compilation to establish a 
new COSMOS TTC dataset of 552 chemicals and point of departure (POD) values.  
 
Figure 2 The curation process for the COSMOS TTC dataset 
2.2.1 Oral repeated-dose toxicity database (oRepeaTox DB)  
The oRepeaTox DB was developed to address the issue of the relative lack of readily 
available data on toxicity of chemicals related to cosmetics. It contains oral, repeated-
dose, non-cancer toxicity data for cosmetics-related chemicals from subchronic, 
chronic, carcinogenicity (non-neoplastic findings only), reproductive, and 
developmental studies. Other study types such as local irritation studies or 
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sensitisation studies did not meet the study inclusion criteria and were not considered. 
The data were compiled from the following publicly available sources: opinions of the 
European Commission’s Scientific Committee on Consumer Safety (EC SCCS) 
(European Commission, 2017), opinions of the European Food Safety Authority 
(European Food Safety Authority (EFSA), 2017), Registration, Evaluation, 
Authorisation and Restriction of Chemicals (REACH) Registered Substance Database 
of the European Chemicals Agency (ECHA) (ECHA, 2017), documents from the US 
FDA CFSAN3 and the US FDA Priority-based Assessment of Food Additives (PAFA) 
(Benz & Irausquin, 1991), documents from the US Environmental Protection Agency 
(US Environmental Protection Agency (EPA), 2016), the National Toxicology Program 
(NTP) database (US Department of Health and Human Services, 2017), and open 
literature publications. Data were compiled from these sources by manual harvesting. 
The new oRepeaTox DB provided 341 studies for 228 cosmetics-related chemicals 
(Gocht and Schwarz, 2014). The study counts from the above sources are: EU 
SCCS/SCCP/SCCNFP (118), US FDA CFSAN (107), REACH ECHA (42), open 
literature publications (39), US NTP (21), US FDA PAFA (9), and US EPA (5). 
Data were compiled into a data entry tool prepared by the COSMOS DB team. The 
COSMOS consortium provided three groups for this activity: 1) the content group 
manually curated the data from the above sources; 2) the software group 
implemented the database technology; 3) a data expert/master curator profiled the 
data map, enforced the standards / criteria, and reviewed the quality of the data 
content. To create this new toxicity database, data from several existing databases 
were consolidated following minimum study inclusion criteria, termed COSMOS 
MINIS (MINImum Study) criteria. The COSMOS MINIS criteria for toxicity studies are 
described in Appendix 1. For many cases where regulatory data sources only 
pointed to literature publications or study reports, original papers or documents were 
                                                          
3
 Data from the US FDA CFSAN internal documents were made available by the Office of Food Additive Safety. The 
QC work was conducted at FDA. 
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obtained when possible to capture the detailed dose-level data. For example, some of 
the studies from ECHA, US EPA, US FDA, or US FDA PAFA were re-harvested from 
the full toxicity data available in FDA internal documents, open literature publications, 
or NTP technical reports. All of the test substances from these sources were 
confirmed as cosmetics-related chemicals by using the COSMOS Cosmetics 
Inventory as a reference list. The only exception to this rule was the inclusion of some 
Food Contact Substances and impurities from the US FDA CFSAN’s Food Contact 
Notification (FCN) program in an attempt to include potential impurities from 
packaging materials; 34 out of the 85 such chemicals from US FDA CFSAN’s FCN 
program were found in the Cosmetics Inventory.  
It should be noted that, in this paper, a test substance is distinguished from a 
chemical structure. A test substance is a particular form of a chemical that has been 
used in testing (e.g., in vivo or in vitro assays) and that can be further differentiated by 
attributes such as synthetic routes or manufacturing processes (reagent vs. technical 
grade), which can result in different impurity profiles. For example, trichloroethylenes 
with and without a trace of epichlorohydrin from different manufacturing processes are 
considered as two different test substances although represented as the same 
chemical structure. In addition, a chemical can also be differentiated by either well- or 
ill-defined compositions. Sodium dodecyl (lauryl) sulfate has a well-defined 
composition and is distinguished from the sodium coco-sulfate, which is ill-defined 
due to the range of coco chain length (C8-C18 centered around C12). However, both 
substances can still be represented by the same structure of dodecyl chain. The 
COSMOS TTC dataset is therefore test substance-centric. 
The toxicity information in the oRepeaTox DB is structured such that a particular 
effect for a site at a given dose level is represented for each study for each chemical 
as accurately as possible. Study designs are described in detail for species, sex, 
route and duration of exposure, dose group (levels and number of animals), control 
information, and references. The effects are described by a set of controlled 
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vocabulary and qualified by time of findings, severity, statistical significance, and 
treatment-relatedness. The target sites are further differentiated for organ/system, 
tissue/segment, and cells/organelles. The oRepeaTox DB is available from COSMOS 
DB v2.0 (Molecular Networks, 2017). 
There has also been discussion of whether it would be preferable, from a scientific 
perspective, to use molar quantities of chemical entities and convert NOAELs from 
mg/kg-bw into mmol/kg-bw (Escher et al., 2010; Dewhurst and Renwick, 2013). This 
was not pursued in the present work for the COSMOS TTC dataset since the scientific 
community utilising the TTC approach is mostly working on a mg/kg-bw basis, and 
using that basis allows easier comparisons with other published TTC values. 
2.2.2 Munro TTC dataset 
The current TTC approach for non-cancer endpoints is based on the dataset 
published by Munro et al. (1996). The Munro dataset contains 613 diverse substances 
from 609 unique chemicals. The difference is because the Munro dataset sometimes 
listed the same chemical under different substance names or as duplicate records but 
with different study types and No-Observed-Effect Level (NOEL) values; these include 
5,5-diphenylhydantoin, ascorbic acid, and azorubine (Carmoisine, C.I. ACID RED 14). 
The Munro et al. (1996) database includes aggregated data of study design 
parameters (study type, species, route and duration of exposure, doses), NOEL/LOEL 
values, critical effects, and references. The dataset cited 200 chronic, 233 subchronic, 
89 reproductive, and 91 teratogenicity studies. 
Munro calculated points of departure (PODs) based on “NOEL” values. A factor of 
three was used to adjust the NOEL from studies of shorter than chronic duration and 
designated with an asterisk in the original publication (note that whilst the adjusted 
values were used in the derivation of the TTC values, they were not explicitly cited in 
the published tables but indicated with asterisks). The dataset of 613 substances was 
also divided into the three structural classes defined by Cramer et al. (1978); 137 
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substances to Class I, 28 to Class II, and 448 to Class III. The three Cramer Classes 
became the basis of grouping chemicals in the current TTC paradigm.  
For this study, the Munro dataset was first downloaded from the EFSA website 
(Bassan, Fioravanzo, Pavan, & Stocchero, 2011), then the records were corrected 
back to reflect exactly the same as the original Munro et al. (1996) publication. This 
version is referred to as “Munro-1996” in this present publication and was used 
verbatim for analyses where historical comparisons were important. The content was 
further corrected by COSMOS TTC quality control (QC) as well as additional 
database QC before importing to the COSMOS DB, where the “the updated “Munro-
1996”, is now downloadable (Molecular Networks, 2017). The 190 substances from 
the Munro dataset that appear in the Cosmetics Inventory were considered as 
cosmetics-related chemicals. A large number of studies for these 190 cosmetics-
related chemicals was reviewed by the COSMOS ILSI Europe Expert Group. This 
dataset in general has been also checked for record reliability, including study design, 
results, and references by the COSMOS team. More in depth QC of the Munro 
dataset is described later (Section 2.3.2).  
2.2.3 NO(A)EL/LO(A)EL Database 
To establish a new database of non-cancer oral data that would be suitable for 
derivation of TTC values, additional data from existing sources were included. The 
outcome of this compilation resulted in a new NO(A)EL/LO(A)EL database (see 
Figure 1 and Figure 2), whose values can be used to determine PODs. Here, we 
distinguish between study NO(A)ELs/LO(A)ELs and PODs that were derived from 
NO(A)ELs/LO(A)ELs by the application of extrapolation factors for study duration 
and/or LO(A)EL to NO(A)EL extrapolation. With that, PODs reflect actual or estimated 
(i.e. extrapolated) chronic NO(A)ELs and allow for comparison of substances. To 
select appropriate studies with NO(A)EL/LO(A)EL values, a strict set of TTC study 
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selection criteria has been established, as listed in Table 1, and applied throughout 
the curation process for both PODs and the final TTC dataset. 
Table 1 TTC study selection criteria in defining databases 
Parameters NO(A)EL/LO(A)EL Database COSMOS TTC dataset 
Study type  
Subchronic, chronic, carcinogenicity 
(non-neoplastic data only), 
reproductive, developmental, 
neurotoxicity, immunotoxicity.  
Same criteria as in 
NO(A)EL/LO(A)EL database 
Species  
Rat and mouse (all studies), monkey 
and dog (all studies), rabbit 
(reproductive, developmental).  
Same criteria as in 
NO(A)EL/LO(A)EL database 
Duration  
Greater than or equal to 28 days for 
subacute (short-term) and subchronic 
studies. 
For reproductive, developmental or 
multigeneration studies, requirement of 
“duration days” is not applied.  
Same criteria as in 
NO(A)EL/LO(A)EL database 
Route of 
exposure  
Dietary, drinking water, gavage (or 
intubation)  
Same criteria as in 
NO(A)EL/LO(A)EL database 
Dose levels and 
range  
All studies with dose level and regimen 
information are included. At least one 
control group is required.  
Single dose studies not 
used.  
Separations between dose 
levels (low, mid, high) are 
reasonable.  
Effects  
All effects are recorded using 
controlled vocabulary.  
Systemic effects. 
Reference  
Regulatory submissions, study reports, 
database sources, published literature 
(traceable citations).  
Regulatory sources with 
guideline (GLP) studies 
preferred.  
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The study design parameters required for inclusion of the studies in the 
NO(A)EL/LO(A)EL Database (inclusion rules) are quite similar to those of the 
COSMOS MINIS criteria for the oRepeaTOX DB. Therefore, all data on NO(A)EL and 
LO(A)EL values from this new toxicity database were merged with the data from other 
regulatory or risk assessment sources. Various other POD values for non-cancer data 
were also based on the following: NOELs and LOELs from the Munro dataset, i.e. 
Munro chemicals found in the Cosmetics Inventory; NOAEL, NOEL, LOAEL, LOEL, 
BMD (Benchmark Dose), and BMDL (Benchmark dose lower 95% confidence limit) 
from the US EPA Integrated Risk Information System (IRIS); highest no-effect levels 
(HNELs) and lowest effect levels (LELs) from the US FDA PAFA database; no-effect 
levels (NELs) and LELs from the US EPA ToxRefDB. This integrated collection of test 
substances along with their NO(A)EL values served as a pool for the candidates for 
the COSMOS TTC dataset, which would then only list one selected POD per 
chemical.  
The combined compilation is stored in the COSMOS DB v2.0 as a Safety Assessment 
Database for more than 1,000 test substances, of which 660 were initially identified 
from the COSMOS Cosmetics Inventory as unique chemical structures. It should also 
be noted that percentages of chemical impurities and the active ingredient in the test 
substances used in toxicity experiments can vary widely, depending on methods of 
analysis. This aspect has not been uniformly considered in the development of TTC 
databases because such information is not consistently available for all studies, so 
that correcting some values but not others would lead to distortion of the database. 
Accordingly, no such corrections were made. For these 660 chemicals, preliminary 
NO(A)EL/LO(A)EL values were available for 558 chemical structures. These datasets 
were used to assess the chemical space and served as a basis for the first 
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preliminary dataset for the initial TTC analysis for cosmetics-related chemicals (EFSA, 
2012; European Commission, 2012; Worth et al., 2012) 
2.2.4  COSMOS TTC Dataset 
2.2.4.1 Creation of the dataset  
The candidate studies in the NO(A)EL/LO(A)EL Database, which provided a first 
round of initial NOAEL/LOAEL values, were selected from thousands of studies by 
applying a set of rules, as described in Table 1. The COSMOS TTC dataset was 
created by applying a further set of rules for POD selections in addition to the TTC 
study inclusion rules related to data interpretation for the candidate chemicals in the 
NO(A)EL/LO(A)EL database.  
This new non-cancer COSMOS TTC dataset contains 552 structures that are mostly 
cosmetics-related chemicals found in the COSMOS Cosmetics Inventory (85%), with 
the rest being food contact substances and impurities. The largest sources for the 
substances in the COSMOS TTC dataset are US FDA PAFA and CFSAN documents, 
cosmetics chemicals in the Munro dataset, the EU Scientific Committee on Consumer 
Safety (EU SCCS/SCCP/SCCNFP), and EPA ToxRefDB. 
Consideration was given to the inclusion of prohibited and restricted substances in the 
databases. Currently, 1,379 substances are listed as prohibited or restricted in the 
use of cosmetic products by Annexes II and III of the EU regulation on cosmetic 
products (European Commission, 2009). Over 30 of these substances are still found 
in the CosIng database, many of them are botanicals and petrochemicals. Others 
include butane, isobutane, C21-C28 alkanes, dibutyl phthalate, diethylhexyl phthalate, 
butyl benzyl phthalate, oxyquinoline/sulfate, ergocalciferol, and retinoic acid. The 
prohibited and restricted list identifies a substance in conjunction with specific use 
category such that a substance can be prohibited for one use category, but still 
allowed to be used in another. In other cases, a substance might be banned from use 
in any cosmetic in the EU but not necessarily in all geographies. For this reason, 27 
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substances that are in the list of prohibited substances for use in cosmetic products in 
the EU remain included in the COSMOS TTC dataset. 
The COSMOS TTC dataset consists of two domains. The first is a test substance-
centered chemistry domain, containing substances used in the study, chemical 
structures, identifiers, physicochemical properties, CAS RN, and Cramer Class 
designation. For TTC, only those chemicals that are representable by structures and 
hence classifiable by Cramer Classes are considered. The second is a toxicity study 
domain, containing the background information, study design parameters and study 
references linked to the aggregated study results of NOAEL and LOAEL (or 
equivalent) values along with critical effects. The COSMOS TTC dataset is available 
from COSMOS DB v2.0 (Molecular Networks, 2017) and is also presented in the 
Supplementary Material to this paper. 
2.2.4.2 Selection of the PODs 
To select the POD for a given chemical for TTC derivation from the multiple 
NOAELs/LOAELs or equivalent data from various sources, the following procedure 
was systematically applied: 
1. NOAEL decisions stated in the EC Scientific Committee opinions were in 
general accepted. In particular, the NOAEL/LOAEL value identified by the 
EC SCCS/SCCP/SCCNFP in their calculation of the Margin of Safety 
(MoS) was accepted ”as is” and selected as the COSMOS POD with the 
highest priority. When questions arose due to large discrepancies between 
values from different data sources, careful reviews by the Expert Group 
were conducted. 
2. The NOAEL/LOAEL or equivalent POD value (e.g. BMDL) used to derive 
an Acceptable Daily Intake (ADI) by EFSA, or the Joint FAO/WHO Expert 
Committee on Food Additives (JECFA), or used by the US EPA IRIS to 
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derive a Reference Dose (RfD), was taken and used ‘as is’ unless conflicts 
were found with the decisions from step #1.  
3. The NOEL/LOEL value determined by US FDA CFSAN or reported in the 
Munro dataset was also used “as is” if this was the only data source. When 
conflicts arose with other data sources, studies were reviewed as part of 
the QC process (2.3.2). 
4. Substance entries in US FDA PAFA, US EPA ToxRefDB, or REACH (from 
the Registered Substance Database at ECHA) are associated with many 
studies with varying HNEL/NEL and LEL or NOAEL/LOAEL values for the 
chemical. If the data were of equal quality, then NOAEL/LOAEL values 
were determined by selecting values algorithmically according to the 
following rules. The data quality is defined in detail in 2.3.1. 
a. First the study with the lowest no effect level (HNEL, NOEL or 
NOAEL) that also had a clear lowest effect level (LEL, LOEL or 
LOAEL) was taken. 
b. If the minimum no effect level (HNEL, NOEL or NOAEL) was free 
standing (i.e., the highest dose tested), then the priority was given 
to an alternative pair with a clearly defined lowest effect level 
(LEL, LOEL, or LOAEL) value and a no effect level (HNEL, NOEL 
or NOAEL) value (as shown in Figure 3).  
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Figure 3 Selection of NOAEL from a NOEL/LOEL pair with the lowest NOEL value 
5. The data from the literature or NTP technical reports were evaluated by 
the COSMOS TTC group and NOAEL/LOAEL values were extracted when 
necessary.  
6. Where possible, NOAEL values were taken from chronic studies as the 
TTC values are intended to cover lifetime exposure. In cases where a 
shorter-term study was preferred over a chronic study, the database 
clearly lists the rationale for the choice of study. 
7. NOAELs were adjusted for study duration by applying adjustment factors, 
as follows: 
a. For subchronic studies (84 days – 179 days), an adjustment factor 
of 3 was applied to allow for chronic effects, as was used by 
Munro et al. (1996); 
b. For short-term studies (28 – 83 days), an adjustment factor of 6 
was applied to allow for chronic effects, as recommended in 
REACH guidance (ECHA, 2012); 
c. For reproductive and developmental studies, no duration 
adjustment factor was applied, regardless of whether the effects 
were systemic or reproductive/ developmental in nature. The 
effect of performing such an adjustment was evaluated; see 
Section 2.5.1). 
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8. If no NOAELs were found in the above steps, NOAELs were derived from 
the lowest available LOAEL by applying an adjustment factor of 3. 
9. Where possible, studies conforming to internationally accepted 
guidelines/protocols were preferred. When such studies were not used, the 
database lists the rationale for the choice of study.  
10. After all the NOAEL/LOAEL values were assigned for each chemical from 
each data source, an overlap profile of the PODs was prepared. For each 
chemical, other than the decisions from the EU SCCS/SCCP/SCCNFP, 
EFSA, US EPA IRIS and JECFA, the lowest NOAEL values were selected, 
except for a few cases where weight of evidence was applied, as 
documented in the Supplementary Material. The final NOAEL value for 
each chemical was then used to derive the final POD (POD = NOAEL 
adjusted for less-than-chronic study duration) for calculating TTC values 
for the COSMOS TTC dataset.  
The above process is illustrated in Figure 4. It is worthwhile mentioning that the 
COSMOS TTC preferred to use NOAEL/LOAELs rather than NOEL/LOELs for all 
chemicals which were subject to QC reviews. However, not all chemicals were 
reviewed in detail, and the above description of the different data sources 
demonstrates that multiple chemicals in the dataset are designated as having 
NOEL/LOELs. Furthermore, many older data sources, from a terminology 
perspective, do not distinguish clearly between NOELs and NOAELs. In practice, 
many of the NOAELs in the COSMOS TTC dataset are the same as those reported in 
the original sources, e.g. EC SCCS/SCCP/SCCNFP, US EPA IRIS, US FDA or key 
studies reported in REACH. The remaining NOAELs in the COSMOS dataset were 
decided on the “most appropriate” basis as described above. 
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Figure 4 Process for deriving TTC values from multiple studies 
2.2.4.3 Exclusions and inclusions from the database 
Although it was ascertained that lipid soluble vitamins (A, D, E and K) and amino 
acids did not drive the TTC values (they did not affect the 5th percentile value of the 
NOAELs), they were nevertheless excluded from the database. For nutrients, the 
magnitude of the differences between intakes that are essential for normal 
physiological function and intakes that may be toxic can be relatively small. Hence, it 
is widely recognized that conventional risk assessment approaches for such 
substances are not appropriate since the application of default Uncertainty Factors of 
100 to the PODs for toxic effects can give rise to values that would result in nutrient 
deficiencies. Nutrients have therefore been excluded from the COSMOS TTC dataset.  
Proteins, inorganic substances, organometallic substances, coordination complexes 
and metals were also mostly excluded from the database, as they were in the Munro 
analysis. However, the COSMOS TTC dataset included the organosilicones (part of 
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the organometallic class) to cover siloxane-based chemicals. Also included were 
oligomers and lower molecular weight polymeric surfactants whose repeating unit 
ranges are known (e.g. poly(ethylene glycol) or alcohol ethoxylates). 
2.3 Quality control of the databases 
The three databases illustrated in Figure 2, the oRepeaTOX, the NOAEL/LOAEL 
database, and the COSMOS TTC dataset were compiled from the outputs of many 
different regulatory and advisory agencies and data sources. Hence, it was critically 
important to review the data so that not only the factual records were standardized, 
but also the underlying information was evaluated to obtain coherence and the best 
possible NOAEL/LOAEL decisions. Thus, quality control (QC) included two step-wise 
components.  
2.3.1 Data record reliability 
QC for data record reliability entailed the checking of records in the database in 
comparison with the original sources to ensure that the database records truly 
represent the original sources. At this stage, the NOEL/NOAEL values (if specified by 
the document source) were not questioned per se – the QC evaluated only whether 
they were correctly recorded according to the inclusion criteria (see Table 1 and 
Appendix 1). 
Data record reliability was also assessed to classify or filter out unacceptable studies. 
For data from an existing database, the quality scores from the data source were 
adopted. For example, the US FDA PAFA database and the US EPA ToxRefDB 
classify studies for “completeness” and “data usability”, respectively. These standards 
use regulatory guidelines either from the US FDA Redbook (US Food and Drug 
Administration, 2000) or the US EPA Office of Chemical Safety and Pollution 
Prevention (OCSPP) (US Environmental Protection Agency (EPA), 2003), 
respectively. For the two defining databases (oRepeaTOX DB and COSMOS TTC 
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dataset), if the study design satisfied the respective agency’s guideline, the study was 
deemed to “meet the current standards” or to be “acceptable”. When the study was 
not compliant with the guideline but acceptable according to the COSMOS database 
inclusion criteria in Table 1 and Appendix 1, the study was classified as “not meeting 
the current standards, but meeting the core standards” or as “non-guideline, but 
acceptable”. When the study did not meet the minimum standard for the COSMOS 
database, it was considered “unacceptable by not meeting the core standards” or “not 
usable”. 
New public literature studies were also harvested by COSMOS for the oRepeaTox 
DB. For these, data record completeness was assessed by establishing minimum 
study inclusion criteria and a scoring system. All studies conducted according to 
guidelines from the Organisation for Economic Co-operation and Development 
(OECD, 2014), US FDA Redbook (US Food and Drug Administration, 2000), and US 
EPA OCSPP (US Environmental Protection Agency (EPA), 2003) were accepted. The 
COSMOS MINIS criteria, described in Appendix 1, are less stringent than the 
requirements of the OECD test guidelines but are similar to the US FDA PAFA core 
standards. The US FDA PAFA core standards were established for subchronic, 
chronic, and reproductive/developmental studies. The parameters necessary to be 
reported include study duration, animal species, route of exposure, animal 
age/weight, number of animal/dose/sex, control, number of the doses used, dosage 
regimen, clinical signs, water/food consumption, hematology, clinical chemistry, 
urinalysis, organ weight, general necropsy/macro pathology, and 
micro/histopathology.  
2.3.2 QC for results interpretation 
Further QC on a defined proportion of the substances in the COSMOS TTC dataset 
was undertaken by the COSMOS ILSI Europe Expert Group to define the reliability 
and relevance of the harvested studies to TTC for both chemistry and toxicity data. To 
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ensure that NOAEL values were not simply driven by rote application of the 
algorithms described under Section 2.2.4.2, NOAEL selection was reviewed in detail 
and a consensus decision reached on the final NOAEL values to be assigned. A 
primary consideration was that effects used as the basis of the final NOAEL values 
should represent toxicologically relevant systemic effects and also be relevant to 
humans. A definitive decision on human relevance can typically only be reached in 
cases where there is detailed mode of action information. In the absence of such 
information, it was assumed that an effect could be relevant to humans. For instance, 
if there were histopathological changes in rat kidney, in the absence of any other 
information, it was assumed that this effect is relevant to humans. On the other hand, 
if there was information that the effect was due to a rat-specific pathway (e.g., binding 
to the male rat specific protein alpha 2μ-globulin), it was excluded (US Environmental 
Protection Agency (EPA), 1991).  
As a detailed toxicological review of all data on each chemical was resource 
prohibitive, two approaches were taken to prioritize substances for review. First, the 
most potent substances, those with the lowest 10% of NOAEL values in the entire 
dataset, were reviewed. These substances were considered “high-impact” since their 
potency can markedly affect the 5th percentiles of the NOAEL distributions. QC1 was 
conducted for all studies for which NOAEL values of the substances were found in the 
lowest 10% of the entire dataset; in subsequent QCs, records giving NOAELs in the 
lowest 10% of the values for each Cramer Class were reviewed. Consequently, all 
studies with NOAEL values under 5 mg/kg bodyweight per day (mg/kg-bw/day) were 
reviewed. Secondly, the studies on chemicals for which there were large conflicts 
(high variability) in NOAEL values across different data sources were reviewed. This 
group comprised chemicals with NOAEL values in the range of 5 – 50 mg/kg-bw/day if 
the maximum/minimum ratio was >5, and in the range of 50 – 500 mg/kg-bw/day if the 
maximum/minimum ratio was > 10.  
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Also considered were the results of the EFSA (2012) QC of the Munro et al. (1996) 
dataset for the lowest 10% of NOEL values for 16 Cramer Class I and 50 Class III 
substances whose NOELs were in the lowest 10th percentile. The three NOEL values 
of the Class I substances rejected by EFSA were replaced by values assigned by the 
COSMOS ILSI Europe Expert Group during the QC process since they are found in 
the COSMOS Cosmetics Inventory; these substances were ethyl acrylate, methyl 
methacrylate, and triethylene glycol. NOEL values for non-cosmetics chemicals such 
as phenyl-1-propanol-2 (Class I), azinphos methyl (Class III) and coumaphos (Class 
III) were also rejected by EFSA, and hence were not included the Munro dataset used 
by COSMOS. The NOEL for ascorbic acid (Class I) deemed “not verifiable” by EFSA 
was removed from the Munro dataset. Of the 190 substances in common (overlap) in 
both Munro and COSMOS TTC datasets, 40 NOEL values were scrutinised under QC 
by the COSMOS ILSI Europe Expert Group and these values were used for both 
COSMOS TTC and Munro datasets. Most of the rest of these overlapping 190 
substances were also reviewed for record reliability including study design, results, 
and references. At the end, based on various QC results from EFSA and the 
COSMOS ILSI Europe Expert Group, 91 studies from the Munro dataset were 
included in the COSMOS TTC dataset as the basis of POD. All 190 substances 
common to both Munro and COSMOS TTC datasets are now represented with the 
same NO(A)EL values and studies in the COSMOS compilations. This new Munro 
dataset, after QC of the data records and study QC by the Expert Groups (both from 
EFSA and COSMOS ILSI Europe), is here referred to as “Munro-2016”. The Munro 
dataset file downloadable from the COSMSO DB web site contains both Munro-1996 
(Section 2.2.2) and Munro-2016 (COSMOS QC version) with documentation of QC 
status and rationales. 
The US FDA PAFA database covered a chemical space that was very close to that for 
cosmetics due to similar substance use types; in many cases, it was the only data 
source for many cosmetics-related chemicals. The US FDA PAFA database was put 
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together to assess chemical safety with a hazard identification perspective (Benz & 
Irausquin, 1991). Of the 552 chemicals in the COSMOS TTC dataset, 220 chemicals 
appear in the US FDA PAFA database and 91 PODs were derived from US FDA 
PAFA data. More than 50% of the FDA PAFA chemicals used in this TTC dataset 
were Cramer Class I. Nearly 25% of the US FDA PAFA chemicals in the TTC dataset 
had POD values greater than 500 mg/kg-bw/day, whereas only 10% of the rest of the 
TTC dataset was found within the same potency range. All of the US FDA PAFA 
studies resulting in a POD equal to or less than 5 mg/kg-bw/day were reviewed under 
expert QC; more than 50% of the US FDA PAFA studies resulting in a POD of 
between 5 – 50 mg/kg-bw/day were also reviewed by experts. The ILSI Europe Expert 
Group also revisited some of the substances in the Munro dataset and replaced the 
data for isopropyl alcohol and ethanol with that from more reliable studies. Data for 
dinocap and linamarin (Cramer Class III) were removed as the toxicity data providing 
the lowest NOEL values were from hamster studies, which were excluded by the 
COSMOS MINIS criteria (Table 1 and Appendix 1). In addition, in the COSMOS TTC 
dataset, the studies which used only one dose level of the cosmetics-related 
chemicals in the Munro dataset were also not included. In cases in which the overall 
NOAEL was changed as a result of the QC work and the same substance was also 
present in the Munro dataset, the original NOEL was replaced by the new, revised 
NOAEL value in the Munro-2016 dataset. 
Some phthalates and parabens are included in the COSMOS TTC and Munro 
datasets, but NOAELs for some of these types of substances have changed 
(reduced) considerably over time and some of the toxicity endpoints studied more 
recently have not resulted in consensus regarding repeatability and relevance to 
human health. Accordingly, these substances were scrutinised in the QC process and 
some of the NOAELs were reassigned, including lowering of some of the NOELs in 
the Munro dataset. 
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Although the QC process scrutinized the data for the COSMOS TTC dataset, we have 
not reviewed all of the data, putting more emphasis on the most potent chemicals 
since they are the ones that affect the human exposure thresholds. Overall, 91 POD 
values were determined by the ILSI Europe Expert Group and included in the final 
COSMOS TTC dataset along with the additional 223 reviewed by the master curator 
of the COSMOS DB team. A chronological summary of the COSMOS QC process is 
shown in Table 2. 
Table 2 Summary of the study QC process of the COSMOS TTC dataset by the ILSI 
Europe Expert Group 
QC QC description Results 
Initial preliminary 
dataset (2011) 
• Data record QC • 660 test substances; 558 
structures (v1.3)  
• 385 structures (v1.2) (Worth et 
al., 2012) 
QC1 (2012-2013) 
• Potent chemicals: the lowest 10% of 
the whole dataset  
• Data variability (NOAELs): greatly differ 
across the data sources 
• 68 unique test chemicals were 
evaluated (v1.4, v1.5) 
• Result: 460 (v1.6) 
QC2 (2013-2014) 
• Potent chemicals: the lowest 10% of 
each Cramer Class  
• Data variability (NOAELs): chemicals 
greatly differ across the data sources 
• 57 compounds were 
evaluated 
• Result: 562 (v1.7)  
QC 2a (2014) 
• Compound classes (phthalates, 
parabens) 
• Cosmetics-related chemicals (4) for 
which data were deemed questionable 
by EFSA’s QC of the Munro DB  
• Cramer Class evaluation by COSMOS 
experts 
• 5 parabens, 9 phthalates, and 
4 other unreliable data 
• Result: 558 
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QC3 (2014-2015) 
• Potent chemicals: the lowest 10% of 
each Cramer Class  
• Data variability (NOAELs): chemicals 
greatly differ across the data sources 
• 10 compounds reviewed  
• Result: 560 (v1.8, candidate 
for final)  
COSMOS DB QC 
• Data variability (NOAELs): chemicals 
greatly differ across the data sources  
• Remove intractable data or replace with 
more reliable data  
• Additional 92 compounds 
reviewed 
• Result: 552 (final) 
 
In addition, during the QC process, new supporting studies, where available, were 
added. In making final consensus decisions on NOAEL values to be assigned, the 
following general criteria were applied to these studies:  
 NOAELs should be based on systemic effects;  
 the studies should have Klimisch scores (Klimisch, Andreae, & 
Tillmann, 1997), assigned by the ILSI Europe Expert Group, of “reliable 
without restriction” (score 1) or “reliable with restriction” (score 2); 
studies with Klimisch scores higher than this (score 3 – not reliable, or 
score 4 – not assignable) not to be used;  
 only effects with relevance to humans should be included (default 
assumption is that effects are relevant unless there are convincing data 
to demonstrate otherwise); 
 NOAELs from regulatory sources should be preferred, when available.  
The above criteria were applied to any relevant adverse effects reported in the 
available studies regardless of potential mode of action, e.g. adverse effects by 
cytotoxicity were handled the same as adverse effects by endocrine mechanisms. On 
completion of the QC process, the NOAEL decisions were documented and the 
resulting COSMOS TTC dataset was finalised.  
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2.4 POD distribution and threshold development 
2.4.1 The 5th percentile POD values 
The 5th percentile value for each Cramer Class was determined from the cumulative 
distribution function (CDF) of the POD values, derived as described in 2.2.4.2 and 
Figure 4. The names of the substances within the 5th percentile group for each 
Cramer Class, together with their POD values, are listed in the Supplementary 
Material under “Quantiles”. To derive robust threshold values for TTC, the 5th 
percentiles were determined from either parametric fitting by assuming a lognormal 
distribution or by non-parametric estimation of empirical values. The parametric curve 
fitting of lognormal distribution requires only the estimates for mean and the 
dispersion parameters, e.g. standard deviation of a sufficiently large dataset, obtained 
from fitting each data set to a lognormal distribution. This method provides a common 
standard that does not depend on interpretations or interpolations as long as the log-
transformed data can be assumed to be normally distributed. Non-parametric 
evaluations do not assume that the data are normally distributed, but often apply 
smooth interpolation techniques ranging from simple to empirical smoothed quantiles. 
In this study, non-parametric estimations based on smoothed empirical likelihood 
quantiles using a kernel density estimation were performed (Silverman, 1998). Both 
parametric and non-parametric estimations were calculated from MatLab R2013b 
(MathWorks) (MathWorks, 2017), JMP Pro 11.2.1 (SAS institute) (JMP, 2017), and R-
3.3.2 (R-Project) (The R Project for Statistical Computing, 2017). 
To establish the baseline for the method employed in this study, the Munro thresholds 
were estimated using the same data provided in the appendix of the Munro et al. 
(1996) publication. Since the objective was to confirm that the published values can 
be reproduced, data printed in the 1996 paper were used verbatim even in those 
cases where records were clearly erroneous (e.g. triethylene glycol with incorrect 
NOEL due to dose unit error). Under these constraints, the parametric estimations of 
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the 5th percentile NOEL values for Cramer Class I, II, and III of the Munro-1996 
dataset were 2.90, 0.90, and 0.15 mg/kg-bw/day, respectively. These values are for 
all practical purposes the same as the published values of 3.0, 0.91, 0.15 mg/kg-
bw/day, estimated by a parametric method, for the 5th percentile of Cramer Class I, II, 
III, respectively. Hence, all parametric estimation in this study was based on fitted 
lognormal distribution, uncentered and unscaled quantiles. 
Munro et al. (1996) also reported non-parametric estimations of 5th percentile NOEL 
values of 3.3, 1.6 and 0.12 mg/kg-bw/day for Cramer Class I, II, and III, respectively; 
however, the nature of the non-parametric method used was not indicated in their 
paper. In this COSMOS study, based on the non-parametric method described above, 
the 5th percentiles of the distributions of the Munro-1996 dataset were 2.93, 0.91, and 
0.13 mg/kg-bw/day for Cramer Class I, II, and III, respectively. However, as Munro et 
al. (1996) did not describe the method used, comparison of the respective values is 
not informative. 
The influence of a number of factors on the distributions in this study was evaluated 
without assuming normality. The normality test was performed using the Shapiro-Wilk 
method (1965); pairwise comparisons of the distribution of the Cramer Classes were 
also performed using the non-parametric pair-wise Kolmogorov-Smirnov (pair-wise K-
S) test (Conover, 1999). It is worthwhile to note that the 28 NOEL values of Cramer 
Class II failed to meet the normality test, possibly reflecting the small number of 
values available. The NOEL distributions of the Cramer Class I and II pair, and the 
Cramer Class I and III pair were found to be significantly different. This is discussed in 
more in detail in section 3.3.2. 
2.4.2 Human exposure threshold values 
Munro et al. (1996) developed human exposure threshold values (TTC values) based 
on the parametric estimation of the 5th percentile NOELs for each Cramer Class after 
applying a 100-fold safety factor to the 5th percentile POD values (as illustrated in 
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Figure 3). The TTC values derived by Munro et al. (1996) were 1800, 540 and 90 
µg/person/day (person per day) for a 60 kg person, equivalent to 30, 9 and 1.5 µg/kg-
bw/day, for Cramer Class I, II and III respectively. The same method was applied in 
this project to derive TTC values.  
2.5 Sensitivity analysis 
2.5.1 Duration extrapolation factors for developmental and reproduction 
studies 
For some substances, the lowest reported NOAELs originated from systemic toxicity 
effects on parental animals in developmental and reproductive toxicity (DART) 
studies. This raised the question of whether it was necessary to adjust the NOAEL 
values of non-DART effects for the shorter than chronic exposure duration in most 
DART studies. Non-DART effects included body weight changes (parent, weanling), 
organ weight other than reproductive organs, mortality and clinical signs in adult, 
food/water consumption, and maternal toxicity. For such findings, applying duration 
adjustment factors for non-DART effects is hampered by the lack of a precise 
description of the exposure duration for parental animals in many studies. The DART 
effects include reproductive effects, reproductive organ effects, delayed/retarded 
ossification, teratogenic/malformation effects, embryotoxicity, and embryo-fetal 
development. No duration extrapolation factor was applied to DART effects unless 
specified by Munro publications when dealing with the Munro-1996 analysis. 
The impact of treatment duration in DART studies on non-DART effects was 
systematically evaluated for both the COSMOS and Munro-2016 TTC datasets by 
investigating the NOAEL distribution and hence the 5th percentile value for the 
distributions. The following duration adjustments were chosen by COSMOS and 
applied to the NOAEL values:  
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 1-generation studies: a factor of 6 was applied for short-term duration 
(approximately 56 days for mouse, 70 days for rat). 
 2-generation studies: a factor of 3 was applied for duration equivalent 
to subchronic studies. 
 ≥3-generation studies: considered as chronic duration, hence not 
adjusted. 
 Maternal effects in (pre-natal) developmental studies were not adjusted 
since they arose from dosing of the dams during the already more 
sensitive period of gravidity. 
For the COSMOS TTC dataset, 48 NOAEL values were derived from such studies; 
only one case was reported without the specific study duration. For the Munro-1996 
dataset, 91 reproductive and multigeneration studies were cited with 63 records 
assigned to duration of Not Given (NG); during the QC (Section 2.4), 13 duration 
records were entered.  
Analyses of the impact of duration extrapolation factors for non-DART effects in 
reproductive/multigeneration studies were conducted for all COSMOS TTC, Munro-
1996, and Munro-2016 datasets. Comparisons were made for the changes in 
distributions; statistical inference was made by applying the pairwise K-S test. 
2.5.2 Substance types and chemical classes 
The impact of various substance types and chemical classes on the cumulative 
distribution and the resulting 5th percentile POD values were also evaluated. These 
substances include possible nutrients (see Section 2.2.4.3), hair dyeing agents, and 
the chemicals in the list of substances prohibited (European Commission, 2009) in 
cosmetic products in EU as well as organophosphates and carbamates.  
The database was not evaluated for the presence of chemicals with potential for 
bioaccumulation. 
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2.6 Cramer class evaluation 
2.6.1 Cramer classifications by Toxtree and Munro 
Cramer Classes are given in 1996 publication for chemicals listed in the Munro 
dataset. In this study, Cramer Classes were assigned using various versions of 
Toxtree (Toxtree, 2017). To compare the classifications between Munro and Toxtree, 
the Structured-Data (SD) file was batch-processed within Toxtree. Metal ions (Na+, 
Ca2+, or Fe3+, etc.) were not removed from the connection table due to the nature of 
the questions in the decision tree (Cramer et al., 1978). The comparison of 
assignments for 609 unique structures between Munro and Toxtree v2.6.13 are 
summarized in Table 3.  
Table 3 Comparison of Cramer Classifications between Toxtree v2.6.13 and Munro-1996 
 
Toxtree v2.6.13 
Class I 
Toxtree v2.6.13 
Class II 
Toxtree v2.6.13 Class 
III 
Munro Class I 106 7 24 
Munro Class II 3 15 10 
Munro Class III 4 2 438 
 
The patterns of discrepancies are originated from the interpretations of metal ions for 
salt forms and azo dyes or recognition of easy-to-hydrolyze esters and metabolically-
active functional groups. Classifications of these fifty chemicals have been manually 
reviewed and resolved by the COSMOS Chemistry QC. The results of this 
comparative analysis are captured in the Munro-2016 dataset and the rationales are 
also documented in the export file available from the COSMOS DB v2 TTC export site 
(Molecular Networks, 2017). 
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2.6.2 Cramer Class QC for the COSMOS TTC and Munro Overlap 
During the course of this 5-year project, several versions of Toxtree v2.5 and v2.6 
were released. A number of conflicts in the Cramer classifications assigned by the 
various versions of Toxtree v2.5 and v2.6 were also identified and resolved by 
COSMOS Chemistry QC. In addition, there were 33 common chemicals between 
COSMOS TTC and Munro-1996 dataset, whose Cramer classifications were in 
conflict. These discrepancies between Toxtree and Munro-1996 have been resolved 
as part of COSMOS chemistry QC. In addition, the patterns that emerged from the 
comparative analysis mentioned in 2.6.1 were applied to the rest of COSMOS TTC 
dataset. The Cramer Classes used for the COSMOS TTC dataset are documented in 
detail in the export file available from the COSMOS DB v2 (Molecular Networks, 
2017). The results listed in the export file were obtained using Toxtree v2.6.0. The 
final comparisons in this manuscript were made employing Toxtree v2.6.13. No major 
differences in assignments were found between the two versions.  
2.7 Construction of a federated dataset based on COSMOS and Munro TTC 
datasets 
Although the new TTC dataset enriched with cosmetics-related chemicals is much 
needed, it is also desirable to have one master TTC dataset for non-cancer endpoints. 
To this end, a larger set encompassing greater chemical space based on both 
COSMOS and Munro datasets was established. The federated approach does not 
force integration or merging of all the records as one physical entity, but allows the 
construction of this virtual entity for searching and analysis. Three datasets can be 
identified: COSMOS TTC, Munro, and the overlap.  
There are numerous practical issues that present challenges in joining datasets to 
build one federated set These include consistent study inclusion criteria, regulatory 
perspectives, and enforcing the same decision making process. These issues lead to 
study selection issues when the two PODs from COSMOS and Munro datasets are 
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based on different studies or conflict even when from the same study. Fortunately, in 
this project due to our data curation approach (Section 2.3), approximately 30% of the 
studies cited in Munro-1996 had already been subject to expert QC, and many more 
studies were subject to database QC for record reliability to yield the Munro-2016 
dataset. Another problem also recognized earlier in the project was that there are 
discrepancies in Cramer Class assignments between Munro (1996) and those 
obtained using cheminformatics tools such as Toxtree or the OECD Toolbox. To 
further support the analysis of a federated set of COSMOS and Munro, an additional 
45 Munro structures that are not part of the COSMOS TTC dataset were reviewed to 
resolve the conflicts between the classifications by Munro and Toxtree v2.6.0/v2.6.13 
(see Appendix 2). The resulting dataset is downloadable from the COSMOS DB TTC 
workflow (Molecular Networks, 2017). 
2.8 Characterisation method for the cosmetics chemical space 
2.8.1 Molecular properties 
The chemical space of the COSMOS TTC dataset was characterized from the 
perspectives of both structural features and physicochemical properties. The 
structural feature space was described by ToxPrint chemotypes (Toxprint, 2017). The 
use of this method to profile the chemical space of inventories and databases has 
been reported previously (Richard et al., 2016; Chihae Yang et al., 2015). The 
Structure-Data (SD) files of the Munro and COSMOS TTC datasets were prepared 
based on structures in the COSMOS DB v2. The fingerprint files based on 729 
ToxPrint chemotypes were generated using the ChemoTyper software tool 
(Chemotyper, 2017). 
The property space of the datasets was explored by publicly available CORINA 
Symphony Descriptors Community Edition web service provided by Molecular 
Networks GmbH, Nürnberg, Germany. The whole molecule properties employed to 
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profile the Munro and COSMOS TTC datasets included logP, topological polar 
surface area (TPSA), complexity (computed based on paths, branching, atom types), 
dipole moment, water solubility, and molar volume. 
2.8.2 Visualization methods 
The chemical space of datasets was compared by principal components projections 
(C Yang et al., 2008) and hierarchical clustering methods. These techniques can use 
both structural chemotypes and properties. 
Principal component analysis (PCA) is a multivariate data analysis technique that 
reduces the high dimensionality of domain (such as chemical space) and helps to 
represent the variations with a few latent variables. In this study, PCA has been 
applied using both structural feature and molecular property space. For structural 
feature space, 179 chemotypes matching 4 or more structures were pre-selected and 
linearly combined to form principal components (PC). The scores of a few of these 
PCs were then plotted to visualize the grouping of structures. More detailed methods 
using PC projections based on structural features have been published elsewhere (C 
Yang et al., 2008). For property space, the PCs were extracted using a set of 13 
molecular properties (molecular weight, number of H donors and acceptors, XlogP, 
TPSA, polarizability, dipole moment, aqueous solubility, number of Lipinski rule-of-five 
violations, molecular complexity, ring complexity, and diameter). 
Two-dimensional clustering against both molecular properties and ToxPrint 
chemotypes was performed. Based on their presence in more than 4 structures, 241 
ToxPrint chemotypes were used for hierarchical clustering of the Munro and 
COSMOS TTC datasets. The structures were also clustered using the same set of 13 
molecular properties as in the case of PCA. When clustering with structural features 
such as ToxPrint chemotypes, average linkage method with Jaccard distance was 
employed. Ward linkage method with Euclidean distance was applied for molecular 
properties. Against the two-dimensional dendrogram (the first for structural features 
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using ToxPrint chemotypes and the second for molecular properties), each compound 
was plotted in a scatterplot. In addition, the compounds in each of the Cramer 
Classes can be clustered separately using either ToxPrint chemotypes or molecular 
properties. This analysis can be used to illustrate the structural similarities and 
differences between Cramer Classes and between the TTC datasets.  
 
3 RESULTS 
3.1 Chemistry characterization of the COSMOS TTC dataset 
3.1.1 Profile by data sources 
The final COSMOS TTC dataset consists of 552 substances and NOAEL values, 
which originated from over 1000 studies from 10 different sources. The number of 
chemicals from each data source and their overlapping chemical coverage are 
compared in Table 4. Although there are 613 substances in the Munro dataset, only 
190 of these substances (178 unique chemical structures) are considered as 
cosmetics-related chemicals by the COSMOS Cosmetics Inventory and are included 
in the COSMOS TTC dataset. The initial sources, in the order of where most of the 
data came, were US FDA PAFA database, EU SCCS opinions, Munro dataset, US 
FDA CFSAN public documents, and US EPA ToxREFDB. Most of the data on Munro 
substances came from JECFA, US EPA IRIS, and NTP reports. Other minor data 
sources include the European Medicines Agency/European Agency for the Evaluation 
of Medicinal Products (EMA/EMEA), Deutsche Forschungsgemeinschaft (DFG), US 
EPA public documents, Report to the US Consumer Product Safety Commission by 
the Chronic Hazard Advisory Panel (CHAP), and open literature articles.  
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Table 4 Data sources of substances in the COSMOS TTC dataset 
EU 
SCCS ECHA EFSA 
FDA 
PAFA 
FDA 
CFSAN 
EPA 
IRIS 
EPA 
TOXREF NTP JECFA MUNRO 
 153 5 4 3 2 1 6 5 2 3 EU SCCS 
 
36 4 2 2 0 6 4 2 0 ECHA 
  
25 4 1 0 3 1 4 2 EFSA 
   
220 83 5 24 28 21 36 
FDA 
PAFA 
    
131 3 4 3 5 5 
FDA 
CFSAN 
     
43 8 7 0 25 EPA IRIS 
      
140 35 4 24 
EPA 
TOXREF 
       
79 2 38 NTP 
        
98 93 JECFA 
         
190 MUNRO 
 
 
Although initially a large number of studies were from US FDA PAFA, Munro, and 
ToxREFDB, at the end their contributions to the NOAEL values in the COSMOS TTC 
set was much reduced after the QC process. For example, only 91 NOEL values were 
used out of Munro’s 190 values. Likewise, only 91 HNELs from the PAFA database 
were selected out of the initial count of 220 candidates. Figure 5 depicts the 
contributing NOAEL sources in the COSMOS TTC dataset. 
 
Figure 5 NOAEL sources in the COSMOS TTC dataset 
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3.1.2 Profile by chemical space 
3.1.2.1 Structure space 
The chemical space is characterized by ToxPrint chemotypes and physicochemical 
properties using various categorization methods described in Section 2.8.  
The COSMOS TTC dataset differs from the Munro dataset in that it is enriched with 
substances used as skin and hair conditioners, humectants, hair dyes, 
perfumes/fragrances, antimicrobials, emulsifiers, surfactants, and plasticizers. The 
resulting differences are compared in Figure 6 using the ToxPrint chemotypes. Both 
Munro and COSMOS TTC sets are compared for each chemotype; the longer the bar, 
the higher the frequency of the chemotype in the dataset. Chemical groups with little 
or no representation in the Munro dataset include non-ionic and cationic surfactants 
as well as organosilicone and siloxane compounds. The Munro dataset contains 
higher numbers of organohalides, steroids (none in COSMOS TTC set), and ureas. 
There were 44 organophosphorus (OP) chemicals found in Munro, which were all 
considered OPs involved in acetylcholinesterase inhibition, except for two, inosinic 
acid and its salt. In the COSMOS TTC dataset only one OP is included; all the other 
five were phosphorus-containing flavouring agents, e.g. inosinates and guanylates. In 
the Munro dataset 32 carbamates were found, whilst only 3 were found in the 
COSMOS TTC dataset. 
The COSMOS TTC dataset is enriched with chemicals used as hair dyeing agents. 
These chemicals were intentionally included to provide a realistic coverage of the full 
spectrum from low to potentially high safety concerns for cosmetics-related chemicals, 
which also enhanced the structural diversity and coverage, particularly in the 
important category of Cramer Class III. The hair dyeing agents are represented in 
Figure 6 as nitro benzene, diamino benzene, amino nitro phenol, azo, and ethanol 
amines.  
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Figure 6 Histogram of ToxPrint chemotypes of the chemicals in COSMOS and Munro 
TTC datasets 
The comparison of chemical space can also be visualized as multivariate, as 
illustrated in Figure 7, using the PC-score projections based on the selected ToxPrint 
chemotypes (method described in Section 2.8). The Munro (non-cosmetics) and 
COSMOS TTC datasets are quite well separated in the latent variable space. The 
separation of the two groups was close to 90-degrees to each other, which means 
that their chemical space share little common chemotype profiles. The Munro 
chemicals that are heavily loaded on the PC3 are also mostly Cramer Class III 
structures. Only a handful of COSMOS structures appear in this part of the chemical 
space of Munro Class III. They are Red 28, deltamethrin, tetrabromophenol blue, and 
triclosan. The overlaps (blue diamond in Figure 7) are Munro chemicals appearing in 
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the Cosmetics Inventory defined in Section 2.1, which tend to mostly cluster with the 
COSMOS dataset. 
 
Figure 7 Principal Component Scores projection for COSMOS and Munro TTC datasets 
Both analyses, depicted in the distribution bar chart and the PC projection plot based 
on the ToxPrint chemotypes, provide assurance that concerns about the cosmetics-
relevant chemical space of the current TTC approach can be resolved using this new 
COSMOS TTC dataset. Furthermore, the analyses confirm that the extension of 
chemical space by combining the two datasets is significant. 
3.1.2.2 Property space 
The chemotypes that are unique in cosmetics collections such as the COSMOS TTC 
dataset include surfactants (hydrophobic tails and hydrophilic heads), silicones and 
siloxanes. These surface-active chemicals give rise to physicochemical and molecular 
surface properties that are distinctively different from those of the chemicals in the 
Munro dataset. Figure 8 illustrates how the set of molecular properties defined in 
Section 2.8 describes the chemical space of COSMOS and Munro TTC datasets 
through a PC projection scores plot. In general, these molecular properties do not 
clearly differentiate the COSMOS and Munro TTC datasets. While showing the 
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loadings mostly on PC3, there are almost two separate clusters with positive and 
negative scores for compounds in both COSMOS and Munro datasets (Figure 8). 
 
Figure 8 Properties space of COSMOS and Munro TTC datasets 
Cosmetics ingredients tend to have more extreme values in polarity and diameter 
whereas the Munro dataset has more of smaller more non-polar structures. It is 
notable that chemicals used in cosmetics formulations are scattered much more 
widely. Areas of non-ionic and cationic surfactants as well as long alkyl chain 
carboxylic esters can be easily identified. 
3.1.2.3 Combined Structure-Properties Space  
Chemical space can be also characterized by both structure and properties at the 
same time using a 2-D clustering technique. The multivariate hierarchical clustering 
method was applied to ToxPrint chemotypes and the whole molecule properties.  
The pattern in Figure 9 shows that Munro chemicals are smeared throughout the 2-D 
clustering map of structure and properties, indicating that the collection exhibits very 
diverse characteristics both in chemotypes and molecular properties. 
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Figure 9 2-D clustering of Datasets by ToxPrint Chemotypes and Molecular Properties 
On the other hand, the COSMOS chemicals tend to group more tightly in clusters, 
indicating that there are more local areas where structures are more highly correlated 
with properties in the COSMOS dataset. This observation is consistent with the fact 
that physicochemical properties are important in determining the uses of cosmetics. 
3.1.3 Profile by Cramer Classification 
3.1.3.1 Results of Evaluation of Cramer Classification by Toxtree 
Cramer classification is one of the central paradigms of the current TTC approach, 
where the toxicological potency is correlated to structural classes. Therefore, the 
Cramer Classes have a large impact on the 5th percentile NO(A)EL values and TTC 
values. Shortcomings of Cramer classifications using the OECD toolbox or Toxtree 
have already been well documented in previous publications (Bhatia et al., 2015; 
Roberts et al., 2015).  
The comparative analysis of Cramer Class assignments from Munro et al. (1996) and 
Toxtree gave some additional insights. The source of the discrepancies seems to be 
mostly due to the knowledge of chemical reactivity and metabolism. Munro seemed to 
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have applied the knowledge implicitly to such classes as aliphatic (alkenyl and allyl) 
esters, sucrose esters, and 2-butanol. Some examples of the conflicts between Munro 
and Toxtree are summarized in Table 3 and Appendix 2. For example, sucrose 
esters such as sucrose palmitate or stearate are easily hydrolysed to sugar and fatty 
acids, which are natural constituents of the human body and diet, so that the esters 
would be allocated to Cramer Class I based on the original rules while Toxtree placed 
them into Cramer Class III. Another example deals with tautomers (e.g., inosine ring 
where the oxo or oxy forms of the purine-ring are the tautomers). Knowledge of 
tautomers and mesomers becomes important in evaluating certain structures of 
multiple ring system colorants or hair dyes, which Toxtree does not handle well. 
Furthermore, the assignments of sodium or calcium salts to Class III by Toxtree has 
been already documented elsewhere for its interpretation of Rule 4 (Lapenna & 
Worth, 2011; Patlewicz, Jeliazkova, Safford, Worth, & Aleksiev, 2008). Although 
converting the salts to neutral species when preparing structure files is common 
practice, caution is recommended since the original Cramer rules are related to the 
metal salts. The same patterns were also observed in the COSMOS TTC dataset, 
which was accordingly corrected. 
3.1.3.2 Cramer Class distribution 
In comparison to the Munro dataset, the COSMOS TTC dataset is enriched with 
Cramer Class I chemicals and is well balanced between Class I and III. Table 5 
compares the numbers of chemicals in each Cramer Class of the two TTC databases. 
As described previously (Section 2.6), conflicts between the Cramer classifications of 
Munro and COSMOS TTC datasets were evaluated manually by COSMOS Chemistry 
QC.  
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Table 5 Distribution of Cramer Classes in the COSMOS and Munro TTC datasets 
 Cramer 
Class I 
Cramer 
Class II 
Cramer 
Class III 
Total 
COSMOS
1
 219 40 293 552 
Munro-1996
2
 137 28 448 613 
Munro-2016
3 
141 30 435 608 
COSMOS/Munro overlap
1
 112 21 57 190 
Federated set 243 49 671 963 
1
 These counts are the results of COSMOS reviews of the Cramer Classes as 
described in 2.6.  
2 
For Munro-1996 dataset, the assignments presented in the article (Munro 
1996) were strictly followed.  
3
 For Munro-2016 dataset, COSMOS reviews were followed as described in 
Section 2.6.  
 
Approximately 75% (103 out of 137) of the Munro Cramer Class I chemicals are 
cosmetics-related substances. In the overlap between the Munro and COSMOS TTC 
datasets, nearly 60% are Cramer Class I chemicals, whereas only 30% are assigned 
to Cramer Class III. 
3.2 Study Profile of the COSMOS TTC Dataset 
Although the COSMOS TTC approach preferred chronic toxicity NOAELs, the most 
abundant studies in the resulting dataset turned out to be subchronic/short-term 
studies (54%), in particular, rat subchronic studies (49%), as listed in Table 6. The 
frequency of chronic, carcinogenicity, and combined chronic/carcinogenicity studies in 
rats (17%) was similar to that of DART studies in rats (19%). As described in section 
2.2.2, the Munro dataset contains 27% subchronic rat, 31% chronic/combined 
carcinogenicity rat, and 21 % DART rat studies. The COSMOS TTC dataset included 
103 DART studies in rats. The high frequency of DART studies in both datasets 
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demonstrates that DART effects are well covered by the TTC approach. The profile of 
the COSMOS TTC dataset in terms of study types, species and potency of critical 
effects is also illustrated in Table 6. Chemicals tested in subchronic rat studies were 
in general of higher toxicity than those tested in chronic studies. For POD derivation, 
the subchronic and short-term NOAELs were further divided by study duration factors 
of 3 or 6, respectively. 
 
Table 6 Profile of studies and species in COSMOS TTC dataset 
 Median NOAEL (mg/kg-bw/day) and counts 
 Chronic/Carc/Combined1 Short-term/Subchronic DART2 
Rat 212.5 (N=96) 95.7 (N=271) 100 (N=103) 
Mouse 168 (N=14) 100 (N=11) 563 (N=5) 
Dog 37.2 (N=12) 125 (N=16) 15 (N=1) 
Monkey 0.2 (N=1) None 4.1 (N=1) 
Rabbit None None 23 (N=18) 
1 
Chronic, carcinogenicity, and chronic/carcinogenicity combined studies 
2 
Reproductive/developmental including multigeneration reproductive studies 
 
All other combinations of studies and species did not provide statistically large enough 
sampling size to make comparisons. The small number of studies in species such as 
mice, dogs, monkeys and rabbits compared to rats imposes limitations on statistical 
analysis of the influence of species. It should be noted that the Munro-1996 dataset 
does not include any dog or monkey studies. Furthermore, dog and monkey studies 
have a limitation compared to rodent studies in that much smaller numbers of animals 
per dose group are generally used. The most common target organs for these 
cosmetics-related chemicals are liver, kidney, endocrine system (e.g. adrenal, thyroid, 
pituitary), spleen, and gastrointestinal tract as shown in Figure 10. Target organ 
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effects are mostly represented by organ weight changes and pathology changes 
(macroscopic and microscopic). Most common general signs of toxicity include body 
weight changes, and food/water consumption changes. 
 
Figure 10 Target organ profile of critical studies in the database 
There were 91 chemicals with critical effects in rat liver, of which 61 originated from 
subchronic rat studies. For kidney, 61 chemicals were identified with critical effects in 
rats and 59 were from rats in subchronic/short-term studies. 
3.3 POD Distribution of the COSMOS TTC dataset 
3.3.1 General comparisons of POD distribution 
The logPOD distribution of the whole dataset as well as that of each Cramer Class 
was compared for COSMOS, Munro-1996, and Munro-2016 datasets in Table 7. The 
QC results from COSMOS and EFSA shifted the Munro dataset towards less potent, 
although the difference was not statistically significant. 
Table 7 logPOD distribution of TTC datasets 
Cramer 
Class 
COSMOS TTC Munro-2016 Munro-1996 
 Stat description  Stat description  Stat description 
All 
 
Median: 42.2 
Geometric Mean: 43.2 
N: 552 
 
Median: 20.8 
Geometric Mean: 18.4 
N: 611 
 
Median: 18.0 
Geometric Mean: 17.2 
N: 613 
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The median and geometric mean of POD values of the whole COSMOS TTC dataset 
are 42.2 and 43.2 mg/kg-bw/day, respectively. The median and geometric mean of 
POD values for the whole Munro-2016 dataset (N=606) are 20.7 and 18.3 mg/kg-
bw/day, respectively. Interestingly, the median and geometric mean of the Class III of 
the COSMOS TTC dataset were higher than those for the Munro dataset, i.e. on 
average COSMOS Class III was less potent than Munro Class III, but the distribution 
for Class I in the COSMOS TTC dataset was shifted to lower median and geometric 
mean of POD values. 
3.3.2 Cumulative Distribution Functions 
The empirical cumulative distribution function (CDF) curves for each Cramer Class 
are presented in Figure 11, where the abscissa represents the log(POD) values and 
the ordinate gives the cumulative fraction, F(x).  
In the Munro-1996 dataset, although Class I and II overlap at lower POD values, the 
separation of each Cramer Class is clearer than that in the COSMOS TTC dataset, 
where the distributions of the Cramer Class II and III are very similar. For the 
COSMOS TTC dataset, 10% of the data (fraction of 0.1) is below 5.44, 1.67, and 1.67 
mg/kg-bw/day for Cramer Class I, II, and III, respectively. In the Munro dataset, these 
10% quantiles (fraction of 0.1) are 8.24, 1.67, and 0.33 mg/kg-bw/day for Cramer 
Class I, II, III, respectively. 
I 
 
Median: 100 
Geometric Mean: 104 
N: 219 
 
Median: 170 
Geometric Mean: 142 
N: 141 
 
Median: 156 
Geometric Mean: 112 
N: 137 
II 
 
Median: 18.3 
Geometric Mean: 18.5 
N: 40 
 
Median: 27.4 
Geometric Mean: 28.0 
N: 30 
 
Median: 26.3 
Geometric Mean: 24.4 
N: 28 
III 
 
Median: 20.7 
Geometric Mean: 25.1 
N: 293  
 
Median: 10.0 
Geometric Mean: 9.23 
N: 440 
 
Median: 10.0 
Geometric Mean: 9.46 
N: 448 
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Figure 11 Comparison of the empirical cumulative distribution function in the COSMOS 
TTC, Munro 1996 and Federated datasets 
The regions up to 10% quantiles are depicted in more detail in Figure 11. The lower 
end of the CDF near 5th and 10th percentiles illustrates that the Class III of the 
COSMOS TTC dataset may be less potent than that of Munro. The plots also indicate 
that Class II and III of the COSMOS TTC dataset do not separate well and that there 
may be a few more potent chemicals for Class II than in Class III in that region, even 
though Cramer Class II is generally intended to capture chemicals of lower potency 
compared to Cramer Class III. For example, the two Class II chemicals, allyl 
heptanoate and canthaxanthin, are the two most potent chemicals of the COSMOS 
TTC dataset. In the COSMOS TTC dataset, the 10% quantile for Cramer Class I is 
also lower than that of Munro-2016. To test whether the distributions of each of the 
Cramer Classes are significantly different, the pair-wise K-S test was performed. For 
the COSMOS TTC dataset, the differences between Class I & III (p-value=0.0001, 
N=512) as well as between Class I & II were significant (p-value= 0.0001, N=259); 
however, the difference between Class II & III distributions was not significant. Even 
without any chemical insights, this simple statistical test further suggests that there is 
not a solid basis to distinguish between Cramer Class II and Class III in the COSMOS 
TTC dataset. Similar observations were found in the Munro-1996 dataset regardless 
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of the Cramer classification methods used (COSMOS experts, Munro, Toxtree). 
However, in their 1996 publication Munro et al. stated that the distribution difference 
between Cramer II and III was statistically significant. This statement could only be 
reproduced if the raw NOEL values of the original dataset were compared (p-
value=0.0309, N=476) without applying the study duration factors. Since the approach 
chosen for this project was to analyse distributions and 5th percentiles after all the 
adjustments are made, the use of raw NOEL values for the significance test was not 
appropriate.  
3.3.3 Effect of adjustment for DART study duration 
In DART studies, the reliability of recording treatment duration can be challenging and 
hence making the duration adjustment of non-DART POD values from DART studies 
difficult. To this end, the effect of duration adjustment for DART studies on the POD 
distributions and 5th percentile values were evaluated for both COSMOS and Munro 
TTC datasets. Since the Cramer Classifications affect the distribution significantly, the 
criteria used to establish the COSMOS TTC dataset were applied also to the Munro 
dataset for this comparison.  
The 5th percentile POD values in Table 8 indicate that that duration adjustments of 
reproductive studies did not result in appreciable changes of the 5th percentile values 
using both non-parametric (shown) and parametric (not shown) methods. In addition, 
the pair-wise comparisons of the observed (non-parametric) distributions using the 
pair-wise K-S test also confirmed that there is no significant impact on the POD 
distributions by the duration adjustment of reproductive studies in both COSMOS and 
the two Munro TTC datasets (Munro-1996 and Munro-2016). Therefore, in the final 
COSMOS TTC approach, no duration adjustment factors were applied to reproductive 
studies.  
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Table 8 Effect of adjusting for DART study duration on POD distribution*† 
Cramer 
Class 
COSMOS 5
th
 percentile 
POD values 
Munro-2016 5
th
 percentile 
POD values 
Munro-1996 5
th
 percentile 
POD values 
without 
adjustment 
with 
adjustment 
without 
adjustment 
with 
adjustment 
without 
adjustment 
with 
adjustment 
Cramer I 3.42 (N=219) 
3.40 
(N=217) 
3.78 
(N=141) 
3.78 
(N=141) 
2.91 
(N=137) 
2.93 
(N=137) 
Cramer II 0.41 (N=40) 0.41 (N=40) 0.91 (N=30) 0.96 (N=30) 0.85 (N=28) 0.91 (N=28) 
Cramer III 0.93 (N=293) 
0.86 
(N=291) 
0.13 
(N=435) 
0.12 
(N=435) 
0.14 
(N=448) 
0.13 
(N=448) 
*Non-parametric estimation method was used as described in Section 2.4. 
†
Chemicals associated with DART studies whose duration is not clear were not included in this 
analysis. 
3.3.4 Effect of study QC on 5th percentile 
In establishing the databases that contribute to the final estimates of TTC values for 
substances used in cosmetics, a considerable effort was made during the curation of 
the chemical and toxicological information contained in the databases to ensure 
quality. The transparent and rigorous processes used for study selection and QC of 
the toxicity data have been described. Particular scrutiny was undertaken on the most 
potent sections of the COSMOS TTC dataset in order to establish robust 5th percentile 
POD values. Statistical testing of the hypothesis on whether the QC process shifted 
the datasets toward less potency has been conducted before and after QC1 (dataset 
version v1.4 and v1.5) applying the pair-wise K-S test. None of the increases in the 
5th percentile POD values of each Cramer Class before and after the QC was 
significantly different.  
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3.4 Federated TTC dataset of COSMOS and Munro 
As described in section 3.1.2, the chemical space of both Munro and COSMOS TTC 
datasets can be improved when augmented by each other. In addition, it would be 
beneficial to provide a TTC approach based on one master database rather than 
separated by the substance use types (e.g., cosmetics, pesticides, antimicrobials, 
etc.).  
In this study, since systematic and thorough QC efforts had been undertaken by the 
COSMOS partners, the overlap between COSMOS TTC and Munro datasets was 
simply replaced by COSMOS content in the case of Munro-2016. The final count was 
963 substances with 243 for Cramer Class I, 49 for II, and 671 for III. This was an 
increase of over 75% for Class I and II, and a 50% increase for Class III. To test 
whether the distributions of each of the Cramer Classes are significantly different, the 
pair-wise K-S test was performed. For the federated set, as shown in the CDF (Figure 
11), the differences between Class I & III (p-value <0.001, N=914) as well as between 
Class I & II were significant (p-value<0.001, N=292), whilst the difference between 
Class II & III distributions was not significant. In contrast to the COSMOS TTC 
dataset, in the federated dataset, the lowest quartiles of the PODs of Cramer Classes 
II and III do not overlap quite as much, retaining the empirical CDF shape of the 
Munro dataset.  
3.5 TTC analysis 
TTC values were derived from the 5th percentiles based on POD results in the 
COSMOS TTC dataset as demonstrated in Figure 11 and the previous sections. From 
this point on, whenever comparisons were made between the COSMOS TTC and 
Munro datasets, the same adjustment factors were used for both datasets so that 
meaningful comparisons could be made. In addition, a revised dataset denoted as 
Munro-2016 was used for analysis after correcting some Cramer classes and other 
errors of the Munro-1996. 
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3.5.1 Fifth percentile comparisons 
The 5th percentile POD values for each Cramer Class in the COSMOS TTC and 
Munro datasets are summarized in Table 9. As expected, the 5th percentile of Cramer 
Class I of the COSMOS TTC dataset was higher than that of Class II or III. For 
Cramer Class III, the COSMOS TTC dataset gave a higher 5th percentile value than 
that of Munro. However, the 5th percentile value for Cramer Class II in the COSMOS 
TTC dataset was lower than those for other Cramer Classes. As explained earlier in 
section 3.3.2, the Cramer Class I/II and I/III are statistically significantly different, but 
not III/II based on the pair-wise K-S Test. The possible reasons were presented in 
previous sections. 
Table 9 Summary of 5th percentiles POD values for COSMOS TTC / Munro datasets 
 
Datasets 
5
th
 percentile POD values (mg/kg-bw/day) 
Cramer I Cramer II Cramer III 
non-
parametric 
COSMOS
§
 3.42 (N=219) 0.41 (N=40) 0.93 (N=293) 
Munro-2016
§
 3.78 (N=141) 0.91 (N=30) 0.13 (N=435) 
Munro (published value)
†
 3.30 (N=137) 1.6 (N=28) 0.12 (N=448) 
Federated set 3.54 (N=243) 0.74 (N=49) 0.22 (N=671) 
parametric 
COSMOS
§
 4.20 (N=219) 0.58 (N=40) 0.79 (N=293) 
Munro-2016
§
 4.90 (N=141) 1.07 (N=30) 0.15 (N=435) 
Munro (published value)
†
 3.0 (N=137) 0.91 (N=28) 0.15 (N=448) 
Federated set 4.57 (N=243) 0.62 (N=49) 0.23 (N=671) 
§ 
Adjustment factors and Cramer Classifications were applied according to the COSMOS TTC 
criteria. Analysis methods are described in Section 2.4.1. 
† 
Listed are the original Munro published values for the 5
th
 percentile (Munro et al., 1996). 
Issues related to reproducing these values for Munro-1996 dataset are discussed in Section 
2.4.1. 
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The selection of Munro et al. (1996) for Cramer Class II chemicals illustrated that the 
raw NOEL distribution (without any duration adjustments) was significantly different 
(p=0.0309) from that of Cramer Class III; however, in the COSMOS TTC dataset even 
the distributions of the raw NOAEL values of Cramer II and III were not significantly 
different although the sample size is larger. Therefore, reasons other than just the 
sample size also need to be considered. Both Munro and COSMOS TTC datasets 
have 28-40 chemicals in Cramer Class II. The low number of chemicals means in 
practice that the one or two chemicals with the lowest NOAELs can dramatically shift 
the threshold for Cramer Class II. Indeed, this was the case for the Class II chemicals 
allyl heptanoate (NOAEL=0.125 mg/kg-bw/day) and canthaxanthin (NOAEL=0.2 
mg/kg-bw/day), the two chemicals with the lowest NOAELs of the entire COSMOS 
TTC dataset. In contrast, the numbers of chemicals are such that the Cramer Class I 
and III distributions are robust and the thresholds do not change if some PODs are 
updated.  
Table 9 also shows that the POD values do not change statistically significantly 
between COSMOS, Munro-2016, Munro-1996, and the federated dataset of Munro-
2016-with-COSMOS; this demonstrates the robustness of the 5th percentile thresholds 
for Cramer Class I and III. Thus far, the federation of the two existing datasets has 
shown that the chemical space can be expanded and complementary and that the 
human exposure threshold values still broadly support the existing TTC values. This 
analysis provides powerful utilitarian value by pooling the appropriate data for TTC 
approaches. 
3.5.2 Human exposure threshold values 
Three aspects can be summarized for chemicals in the COSMOS TTC dataset of 
cosmetics-related chemicals: (1) Cramer Class I is still less potent than Cramer Class 
III; (2) Cramer Class II results in a slightly lower 5th percentile value than Cramer 
Class III within the constraints of the small sample size for Class II; (3) the overall 
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distribution patterns and the ranges in the COSMOS TTC dataset are broadly similar 
to those of the Munro datasets (including Munro published values, Munro-1996, 
Munro-2016). Therefore, based on the Munro approach, the human exposure 
thresholds for cosmetics-related chemicals have been derived from the COSMOS 
TTC dataset by applying a 100-fold safety factor to the 5th percentile POD values. No 
TTC value is proposed for Cramer Class II of the COSMOS TTC dataset since the 
Cramer II and III distributions overlap in this dataset (Figure 11). This is consistent 
with proposals of EFSA and WHO (EFSA, 2016). If Classes II and III are combined, 
the parametric estimation of the fifth percentile is 0.76 mg/kg-bw/day, which is 
practically equivalent to the Cramer Class III value of 0.79 as shown in Table 9. The 
human exposure threshold values (TTC values) for the four different datasets are 
listed in Table 10, expressed in both μg/person day and μg/kg-bw/day. 
Table 10 Comparison of Human Exposure Threshold Values* 
Datasets 
(number of 
chemicals) 
Human exposure threshold 
values (μg/person/day)  
Human exposure threshold values  
 (μg/kg-bw/day) 
Cramer 
Class I 
Cramer 
Class II 
Cramer 
Class III 
Cramer 
Class I 
Cramer 
Class II 
Cramer 
Class III 
COSMOS 
(552) 
2500 NA 470 42 NA 7.9 
Munro-1996
†
 
(613) 
1800 540 90 30 9.0 1.5 
Munro-2016 
(606) 
2900 640 90 49 11 1.5 
Federated set 
(963) 
2700 370 140 46 6.2 2.3 
*
All threshold values were calculated by parametric estimation of the cumulative distribution. 
Per person values were calculated based on a default body weight of 60kg. 
†
 These values are verbatim copy of the Munro 1996 publication. 
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TTC values for cosmetics-related chemicals in the COSMOS TTC dataset can be 
compared with the currently widely-used TTC values proposed by Munro et al. in 
1996 for food-related chemicals. Except that the Cramer Class III is significantly less 
potent in the COSMOS dataset than in the Munro dataset, the two datasets show 
similar distribution characteristics. When the two sets are federated, the resulting 
cumulative distributions for the three Cramer Classes were not significantly different 
from the Munro dataset based on pair-wise K-S tests. 
 
4 DISCUSSION 
4.1 Impact on chemical space enrichment 
Until now, there has not been a dataset available that enables the application of the 
TTC approach to cosmetics products to be addressed specifically. The COSMOS 
TTC dataset, which has been rigorously curated and collated, fills that gap. It contains 
cosmetics-related chemicals, including some more complex molecules such as hair 
dyes. Although there is some overlap between the COSMOS TTC and the Munro 
datasets, in Cramer Class I, 65% of the chemicals in the COSMOS TTC dataset are 
different from those in the Munro dataset; in the important Cramer Class III group, 
81% of the COSMOS TTC chemicals are different from those in the Munro dataset. 
The COSMOS TTC dataset also has a more even split between Cramer Class I and 
Class III than the Munro dataset (both Munro-1996 and Munro-2016).  
These descriptive differences are also apparent graphically in a clustering map where 
structures defined by ToxPrint chemotypes are again clustered for Cramer Classes as 
depicted in Figure 12. 
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Figure 12 Visualization of chemical space differentiation of Cramer Classes in COSMOS 
and Munro-2016 TTC datasets 
There are structural clusters showing up in Munro Cramer Class III, but not observed 
(white space in the vertical bar for each Cramer Class) in the COSMOS TTC dataset. 
It is also the case that some structural clusters appear only in COSMOS Cramer 
Class I (as shown in Figure 11); the same is true for Munro Class III. Similar 
observations are also illustrated when scores of the principal components are plotted. 
The Cramer Class III structures in Munro-2016 (salmon) and COSMOS (lavender) 
share very few commonalities in the chemical space. It is also the case that the 
structures of the Cramer Class I and III from both datasets are separated. Therefore, 
characterisation of the chemical space occupied by the COSMOS TTC dataset has 
demonstrated that it is different from that of the Munro-2016 dataset, for both Cramer 
Class I and III. It is also significant from Figure 12 that the chemical space of Class III 
is now further expanded beyond that of the Munro-2016 dataset when the cosmetics 
chemotypes are added. 
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The new database has also been profiled for study types/species, critical effects and 
target organs; through this analysis, it has been demonstrated that the studies 
included are diverse and broadly cover the critical effects that are important in 
systemic toxicity safety evaluations. In line with the Munro et al. (1996) and Kroes et 
al. (2004) work on TTC, short term and dermal studies were not included in the 
database, so that this project did not consider local effects or hypersensitivity effects 
unless they drove the NOAELs in oral repeated dose studies.. Taken together, the 
above features provide confidence in the applicability of the COSMOS TTC dataset to 
cosmetics-related chemicals and hence the use of the dataset to evaluate the 
appropriateness of the TTC values for such chemicals. 
The POD values in the new COSMOS TTC dataset span six orders of magnitude, 
which is similar to that in the Munro dataset. When expressed on a body weight basis, 
the parametric TTC value derived from the 5th percentile POD value for Cramer Class 
III in the COSMOS TTC dataset is 7.8 µg/kg-bw per day, which is 5-fold higher than 
the corresponding TTC value of 1.5 µg/kg-bw per day that was derived by Munro et 
al. (1996). The TTC values obtained for Cramer Class III of Munro-1996 and Munro-
2016 datasets were the same as that reported by Munro et al. (1996). On the other 
hand, the TTC value for Cramer Class I was slightly increased from 30 µg/kg-bw per 
day in the Munro-1996 dataset to 49 µg/kg-bw per day in the Munro-2016 dataset in 
which the QC results from both COSMOS and EFSA, Cramer Class reviews, and 
COSMOS rules for study duration were applied (described in Section 2.2). This was a 
numerically higher value than the Cramer Class I value for the COSMOS TTC dataset 
of 42 µg/kg-bw per day. It was not unexpected that the new database is overall less 
potent than the Munro dataset since the content was enriched with cosmetics-related 
chemicals and it would be expected that such chemicals, for use in personal care 
products, would have generally lower toxicity compared with that of the broader 
universe of chemicals.  
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4.2 Other factors affecting the 5th percentile POD and TTC values  
4.2.1 Effects of certain chemical classes and substances 
As discussed in section 3.1.2.1, the chemotypes were applied to the two TTC 
datasets to distinguish the chemical space (illustrated in Figures 6, 7, 9, 12). Using 
this approach, identification of OPs, carbamates or hair dyeing agents can be easily 
achieved and the resulting sets were analysed for their influence on the 5th percentile 
POD values. In the COSMOS TTC dataset, only one OP (POD=1.67 mg/kg-bw/day) 
and 3 carbamates (POD=2.67, 5.0, 100.3 mg/kg-bw/day) were found. Removing 
these compounds did not have any impact on the 5th percentile POD for Class III of 
the COSMOS TTC dataset.  
Also considered was the addition of 122 hair dyeing agents to reflect the needs of the 
European cosmetics regulation. As most of these chemicals were in Cramer Class III 
(109) and only 13 in Class I, the impact of this addition to the dataset needed to be 
evaluated in both chemical space and POD distributions. These hair dyes are in a 
structural island, almost exclusively by themselves, as shown in the PCA projections 
(Figure 13), occupying chemical classes of ethanolamine, phenolic amines, and 
aromatic nitro. When using ToxPrint chemotypes that appear in more than 4 
structures, the two sets are clearly separated almost exclusive (orthogonal) to each 
other with the first few principal components.  
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Figure 13 Principal component projection of hair dyes based on Chemotypes 
The impact of hair dyeing agents on the 5th percentile POD values is summarized in 
Table 11. Also examined were the substances prohibited for use in cosmetics by EU 
regulation (Section 2.2.4.1). 
Table 11 Effect of hair dyes on 5th percentile POD values 
 Non-parametric estimation of 
 5
th
 percentile POD value of COSMOS TTC dataset 
 All hair dyes prohibited substances 
Cramer Class I 3.42 (N=219) 3.50 (N= 206) 3.54 (N=210) 
Cramer Class II 0.41 (N=40) 0.41 (N=40) 0.38 (N=39) 
Cramer Class III 0.93 (N=293) 0.77 (N=184) 1.04 (N=274) 
 
The exclusion of these hair dyeing agents or the EU-prohibited list did not affect the 
5th percentile POD value or the distributions significantly, judging from the pair-wise K-
S test. This analysis confirms that hair dyeing agents and substances prohibited for 
use in cosmetics can be included in the COSMOS TTC dataset to enrich the chemical 
space without impacting the POD distribution and 5th percentile.  
 67 
 
4.2.2 The effect of Cramer classifications 
Other than the importance of study quality that drives the POD decisions, one of the 
most important factors impacting the TTC thresholds is the Cramer classifications. 
Although Cramer Class II chemicals in the COSMOS TTC dataset have a slightly 
lower 5th percentile POD value than Cramer Class II chemicals in the Munro dataset, 
the significance of this difference is unclear due to the small sampling size for Cramer 
Class II chemicals in both databases (the COSMOS TTC dataset has 40 chemicals in 
Class II, and Munro has 28). For example, one of the chemical classes below the 5th 
percentile POD value of the Class II group in the COSMOS TTC database is allyl 
carboxylic esters, which is known to be quite reactive and toxic. Therefore, in addition 
to the fact that the POD distributions of Class II and III are not significantly different, 
the possibility still exists that the chemical space of Class II for cosmetics-related 
chemicals may be different than that of other chemicals. The difficulty of finding 
sufficient chemicals to populate Cramer Class II and provide a meaningful analysis 
has been noted by others using different databases (Batke et al., 2011; EFSA, 2012; 
Escher et al., 2010; Feigenbaum, Pinalli, Giannetto, & Barlow, 2015; Munro et al., 
1996; Pinalli, Croera, Theobald, & Feigenbaum, 2011; Tluczkiewicz, Buist, Martin, 
Mangelsdorf, & Escher, 2011). The present study also found that there were 
insufficient chemicals in Cramer Class II for a meaningful analysis and derivation of a 
reliable TTC value for this Cramer Class with the database at hand. This does not 
automatically imply that other datasets with focus on specific chemical classes cannot 
lead to more robust Cramer Class II distributions. Hence, for the present project, 
Cramer Class II chemicals were still analysed separately to enable comparison with 
previous analyses and also to make the data more easily accessible for potential 
future research. 
Another factor to consider is the assignment of Cramer Classes, which can have an 
impact on the TTC thresholds derived. There has been considerable discussion of the 
 68 
 
Cramer classification system, which was first proposed by Cramer et al. (1978). It has 
been deemed still fit for purpose by European advisory bodies (EFSA, 2012; SCCS, 
SCHER, 2012). However, the fact that it was developed on the basis of toxicological 
knowledge of several decades ago and because users of the Toxtree software for 
assignment of Cramer Classes have raised questions about inconsistencies and 
problems with some of the steps in the Cramer decision tree, the need to revise some 
aspects of the decision tree has been discussed and certain changes have been 
proposed (Bhatia et al., 2015; Dewhurst & Renwick, 2013; European Food Safety 
Authority (EFSA) & (WHO), 2016; Lapenna & Worth, 2011; Patlewicz et al., 2008; 
Roberts et al., 2015). Some of the proposed changes have been implemented in the 
Toxtree software. In the development of the COSMOS TTC dataset, a number of 
substances had to be manually reassigned for Cramer Class. At this present point, we 
recommend that users of the TTC approach be aware of potential problems and have 
the opportunity to consult suitable experts that can manually check the assignment of 
Cramer classifications. 
4.2.3 Assessing dermal exposures with oral TTC thresholds 
The purpose of this project was to improve the scientific basis of and confidence in 
applying the TTC concept to assess exposures arising from cosmetics-related 
chemicals. It is acknowledged that most exposures from cosmetic products will occur 
via the dermal route. However, for most substances, many more repeated-dose oral 
studies have been carried out than repeated-dose dermal studies, even for 
substances that are dermally applied to humans. Thus, the database of available 
dermal repeated dose studies is too small to derive meaningful distributions and 
thresholds. In addition, for many substances, systemic exposure from oral 
administration is known to be higher than from dermal application (Williams et al., 
2016). Therefore, risk assessment based on TTC thresholds will have to make use of 
route-to-route extrapolation methods, as further elaborated by the other COSMOS 
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ILSI Europe Expert Group (Williams et al., 2016). This situation is in no way different 
from dermal risk assessment when only oral toxicity studies are available on the 
chemical in question. Derivation of PBPK modelling-based internal TTC values has 
been proposed (Partosch et al., 2015) and is being further evaluated, but is also 
challenging due to the amount of data needed to develop relevant estimates of 
internal doses arising during oral toxicity studies on one hand, and from dermal 
exposure on the other hand. The COSMOS project has provided a robust and 
relevant oral database and TTC thresholds valid for chemicals related to cosmetics, 
which can be applied in risk assessment in the same way as substance-specific 
toxicity data from oral, repeated-dose studies.  
4.2.4 The new COSMOS TTC dataset as part of the TTC concept 
This project developed an enhanced oral non-cancer TTC dataset with larger 
chemical domain, which is intended to be used as a part of the broader TTC concept 
as developed by Kroes et al. (2004), including refinements thereof. It is not 
recommended to use this TTC dataset, or the thresholds derived, in isolation. Hence, 
the exclusion criteria for chemicals and effects not included in the database (e.g. 
proteins and sensitisation) and effects of specific concern (e.g. potent carcinogens) 
also apply to the TTC concept when using this dataset.  
 
5 CONCLUSION 
This study presents a new, transparent and public TTC database of 552 cosmetics-
related chemicals. The COSMOS TTC dataset is publicly downloadable at the 
COSMOS DB v2.0 website (Molecular Networks, 2017). The 5th percentile POD value 
for each Cramer Class was determined, from which human exposure threshold values 
(TTC values) have been derived. The number of substances classified in Cramer 
Class II was insufficient for derivation of a robust TTC value. TTC values of 42 and 
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7.9 µg/kg-bw/day for Cramer Class I and Cramer Class III, respectively, have been 
derived for the COSMOS TTC dataset and TTC values of 46, 6.2 and 2.3 µg/kg-
bw/day for Cramer Class I, Cramer Class II and Cramer Class III, respectively, of the 
COSMOS-plus-Munro federated dataset. This study also showed, through federation 
of datasets, that the TTC approach first proposed by the pioneering work of Munro et 
al. (1996) still holds in a broad sense even after updating multiple details and when 
many more cosmetics-related chemicals are added. The small impact of a 
substantially enlarged database and QC effort demonstrates the power and 
robustness of the probabilistic approach of TTC. 
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APPENDIX 1 COSMOS MINIS Study Criteria 
Study Parameter 
 
Chronic Subchronic Reproductive Developmental Required? 
TEST SUBSTANCE: 
NAME 
text  text  text  text  REQUIRED  
TEST SUBSTANCE: 
NAME SOURCE 
controlled vocabulary 
list 
controlled 
vocabulary list  
controlled 
vocabulary list  
controlled vocabulary 
list  
REQUIRED 
STUDY BACKGROUND: 
GUIDELINE 
controlled vocabulary 
list including non-
guideline study  
controlled 
vocabulary list 
including non-
guideline study  
controlled 
vocabulary list 
including non-
guideline study  
controlled vocabulary 
list including non-
guideline study  
REQUIRED 
STUDY BACKGROUND: 
DATA SOURCE 
GRANULARITY 
controlled vocabulary 
list including summary-
only  
controlled 
vocabulary list 
including 
summary-only  
controlled 
vocabulary list 
including summary-
only  
controlled vocabulary 
list including summary-
only  
REQUIRED only for the 
matched conditions  
STUDY BACKGROUND: 
REFERENCE TYPE 
controlled vocabulary 
list  
controlled 
vocabulary list  
controlled 
vocabulary list  
controlled vocabulary 
list  
REQUIRED 
STUDY: STUDY TYPE controlled vocabulary controlled controlled controlled vocabulary REQUIRED  
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list  vocabulary list  vocabulary list  list  
STUDY: DURATION 6 months - 2 years  90 day; >=28 day 
allowed  
Continuous 
exposure through 
appropriate 
generation weaning  
Implantation through 
organogenesis  
REQUIRED  
TEST SYSTEM: SPECIES rat/mouse/dog/monkey  rat/mouse/dog/m
onkey  
rat/mouse/dog/monk
ey/rabbit  
rat/mouse/dog/monkey/
rabbit  
REQUIRED  
TEST SYSTEM: ROUTE 
EXPOSURE 
diet, drinking water, or 
gavage  
diet, drinking 
water, or gavage  
diet, drinking water, 
or gavage  
diet, drinking water, or 
gavage  
REQUIRED  
TEST SYTEM: 
ANIMAL AGE 
broad description - 
healthy, young adults  
broad description 
- healthy, young 
adults  
broad description - 
young…  
 REQUIRED only for the 
matched conditions 
 
TEST SYTEM: ANIMAL 
TREATMENT 
 
actual weight  
 
actual age or 
weight  
 
Male: treated for 10-
wk prior to mating; 
Female: treated for 2 
weeks  
 
young, mature, 
primigravida, untreated  
REQUIRED only for the 
matched conditions 
TEST DESIGN: ANIMAL 
NUMBER 
rodent - 10/dose/sex; 
dog - 3/dose/se  
rodent - 
10/dose/sex; dog 
rodent or rabbit - 
20/dose/sex  
rodent or rabbit - 
20/dose/sex  
REQUIRED only for the 
matched conditions 
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- 3/dose/se  
TEST DESIGN: 
CONTROL SUBSTANCE 
must be specific  must be specific  must be specific  must be specific  REQUIRED only for the 
matched conditions 
TEST DESIGN: DOSAGE 
REGIMEN 
5 days/ week (gavage); 7 day/week; ad lib  5 days/ week (gavage); 7 day/week; ad lib  REQUIRED only for the 
matched conditions 
TEST DESIGN: NUMBER 
DOSE GROUPS 
2  2  3  3  REQUIRED only for the 
matched conditions 
TEST DESIGN: DOSE 
UNIT 
Dose unit  Dose unit  Dose unit  Dose unit  REQUIRED 
TEST DESIGN: DOSE 
VALUE 
Dose value  Dose value  Dose value  Dose value  REQUIRED 
TEST DESIGN: DOSE TO 
ANIMAL 
Dog/Monkey - dose 
needs to be in mg/kg-
bw/day; Others - PPM 
or % in diet or in water  
Dog/Monkey - 
dose needs to be 
in mg/kg-bw/day; 
Others - PPM or 
% in diet or in 
water  
Dog/Monkey - dose 
needs to be in 
mg/kg-bw/day; 
Others - PPM or % 
in diet or in water  
Dog/Monkey - dose 
needs to be in mg/kg-
bw/day; Others - PPM 
or % in diet or in water  
REQUIRED only for the 
matched conditions 
RESULTS: BODY 
WEIGHT 
start, final; OR start, 
mid-way, final  
start, final; OR 
start, mid-way, 
P1 at start + weekly; 
F1 at birth & d-4,21- 
dams: at start, end of 
dosing and at sacrifice  
REQUIRED only for the 
matched conditions 
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final  weekly thereafter; 
F2 at birth & d-4,21 
(♂ & ♀)  
RESULTS: FODD/WATER 
CONSUMPTION 
need to be mentioned - 
normal or any signs  
need to be 
mentioned - 
normal or any 
signs  
need to be 
mentioned - normal 
or any signs  
need to be mentioned - 
normal or any signs  
REQUIRED only for the 
matched conditions 
RESULTS: GROSS 
NECROPSY 
all usual organs  all usual organs  PREGNANT FEMALE PARAMETERS - 
Corpora lutea; fetal deaths; live fetuses, 
MORPHOLOGY - Visceral, Skeletal, External 
gross examination 
REQUIRED 
RESULTS: 
HISTOPATHOLOGY 
gonads, heart, 
intestine, kidney, liver, 
spleen, stomach (high 
dose minimum); other 
relevant organs  
gonads, heart, 
intestine, kidney, 
liver, spleen, 
stomach (high 
dose minimum); 
other relevant 
organs  
REQUIRED only for the matched conditions  REQUIRED only for the 
matched conditions 
RESULTS: ORGAN kidney, liver, testes; other relevant organs  kidney, liver, testes; other relevant organs  REQUIRED only for the 
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WEIGHT matched conditions  
RESULTS: CLINICAL 
SIGNS 
daily observation; toxic signs; behavior; 
mortality  
daily observation; toxic signs; behavior; 
mortality  
NOT REQUIRED  
RESULTS: 
HEMATOLOGY 
erythrocytes; leukocytes; other relevant 
assays  
erythrocytes; leukocytes; other relevant assays  NOT REQUIRED  
RESULTS: CLINICAL 
CHEMISTRY 
relevant assays  relevant assays  NOT REQUIRED  
RESULTS: URINALYSIS relevant assays  relevant assays  NOT REQUIRED  
The controlled vocabulary list of the database is available from COSMOS DB v2 (COSMOS Parallel Publication).  
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APPENDIX 2. Cramer Class QC 
Name CAS 
Cramer class 
used in this 
study 
Munro 
assignment 
Toxtree 
assignment 
1,3-BUTYLENE GLYCOL 107-88-0 1 1 2 
2-BUTANOL 78-92-2 2 1 2 
ALPHA-TOCOPHEROL 59-02-9 1 1 2 
C.I. FOOD BLACK 1 2519-30-4 1 1 3 
ETHYLENE GLYCOL 
MONOPHENYL ETHER 
122-99-6 2 1 2 
GAMMA-NONALACTONE 104-61-0 1 1 2 
GAMMA-
UNDECALACTONE 
104-67-6 1 1 2 
HEXYLRESORCINOL 136-77-6 2 1 2 
INOSINIC ACID 131-99-7 3 1 3 
LITHOCHOLIC ACID 434-13-9 1 1 3 
METHYLENEBIS, 2,2'- 22656-77-5 1 1 3 
SODIUM ERYTHORBATE 6381-77-7 3 1 3 
SUCROSE 
MONOPALMITATE 
26446-38-8 1 1 3 
SUCROSE 
MONOSTEARATE 
25168-73-4 1 1 3 
CAROTENE, BETA- 7235-40-7 2 2 1 
CAFFEINE 58-08-2 2 2 3 
DIKETOPIPERAZINE 29990-68-9 3 2 3 
FURFURAL 98-01-1 3 2 3 
ISOBORNYL ACETATE 125-12-2 2 2 1 
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METHYL 
ANTHRANILATE 
134-20-3 2 2 3 
PIPERONAL 120-57-0 2 2 3 
PROPARGYL ALCOHOL 107-19-7 2  2 3 
PYRIDINE 110-86-1 3 2 3 
THUJONE 546-80-5 2 2 3 
ALLYL ISOVALERATE 2835-39-4 2 3 2 
ANTHRANILIC ACID 118-92-3  1 3 1 
C.I. ACID RED 14 3567-69-9 1 3 1 
C.I. ACID RED 18 2611-82-7 1 3 1 
CANTHAXANTHIN 514-78-3 2 3 2 
FD&C RED NO. 2 915-67-3 1 3 3 
FD&C YELLOW NO. 6 2783-94-0 1 3 3 
METHYL CARBAMATE 598-55-0 3 3 1 
SODIUM CYCLAMATE 139-05-9 1 3 1 
 
